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Full Name : Sadiq Abdulmohsin Makki Al-Insaif 
Thesis Title : 
An Approach to Identify the Disease-Gene Association Through 
Biological Networks Topological Features 
Major Field : Computer Science 
Date of Degree : May/2014 
Background: biologists generate massive datasets which are difficult to interpret and 
make use of for further diseases analysis. Hence, computational analysis techniques are 
required towards systems biology. There is an urgent need to investigate a system rather 
than evaluating individuals solely. This could be experimentally accomplished through 
studying individuals and then how they are interacting with others, such a concept is 
known as networks. 
Approach: Complex biological networks constitute of thousands of nodes and thousands 
of interactions which could be represented as a graph. So, a graph theory could be 
utilized to rank nodes (i.e. genes) of the biological networks as individuals and as whole 
to retrieve the hidden properties and knowledge. Furthermore, this study applies different 
ranking algorithms (i.e. 14 ranking algorithms are used) and fed as features to two 
classification models which are decision tree bagger (DTB) and random under sampling 
boost (RUSBoost) to investigate the breast cancer genes. More importantly, to overcome 
the problem of the skewed datasets a synthetic minority oversampling technique 
(SMOTE) is adopted in order to transform an imbalanced dataset to a balanced one. 
Finally, we propose our modified co-cross validation technique to compute four-
evaluation metrics (Accuracy, F-Measure, AUC, and Geometric Mean). 
xx 
 
Results: We have extracted fourteen features from publicly co-expression network, 
protein interaction network, and functional interaction network. Then, we use 
classification models to investigate the phenotype-gene association in breast cancer 
genes. Prior classification, a SMOTE sampling technique is utilized in all biological 
networks. By using a Hill-climbing feature selection approach and Pearson correlation 
coefficients, a subset features have been identified as important features to predict 
phenotype-gene association. Specifically, 'within module z-score' is identified as the most 
influential feature to predict breast cancer genes.  
Conclusion: We are able to identify sub-set of topological features that are significant to 
identify the breast cancer genes. We have adopted 'within module z-score' topological 
features to apply in-depth analysis which helped us to identify three genes that are subtle 
to breast cancer genes (i.e. „ZNF22‟, „CUL2‟, and „GTF2F2‟). 
Keywords: Biological network; Machine learning; Decision tree bagger; SMOTE; Breast 
cancer; Gene ranking. 
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 ملخص الرسالة
 
 
 طادق عثذ انًسسٍ يكٙ آل اَظٛف 8الاسم الكامل
 
يٍ خلال انخظائض انًستخشخح يٍ  انشثكاخ َٓح نتسذٚذ انعلالح ياتٍٛ الأيشاع ٔ اندُٛاخ  عنوان الرسالة:
 انثٕٛنٕخٛح
 
 عهٕو زاسة التخصص:
 
 2014/يإٚ 8تاريخ الدرجة العلمية
. الأيشاع نتسهٛم يُٓا ٔالإستفادج تفسٛشْا ٚظعة انتٙ انثٛاَاخ كى ْائم يٍ ٚمٕيٕا تإَتاج الأزٛاء عهًاء المقدمة:
نذساسح الأَطًح انسٕٛٚح  ثٕٛنٕخٛحانشثكاخ ان أَطًح َسٕ انسساتٙ انتسهٛم إستخذاو تمُٛاخ ٚهضو انتٕخّ إنٗ ٔتانتانٙ،
 يع كٛف إٌ الأفشاد تتفاعم ثى ٔيٍ الأفشاد دساسح خلال يٍ تدشٚثٛا ٚتسمك أٌ ًٚكٍ ْٔزا. فمط الأفشاد تمٛٛى يٍ تذلا
  .ٚسًٗ تانشثكاخ انًفٕٓو ْزا يثم انًعشٔف ٔيٍ اٜخشٍٚ،
 ٕضر تإستخذاوت أٌ ًٚكٍ انتٙ انتفاعلاخ يٍ ٔاٜلاف انعمذ يٍ اٜلاف يٍ شكمتت انًعمذج انثٕٛنٕخٛح شثكاخان8 النهج
 انثٕٛنٕخٛح شثكاخان يٍ) اندُٛاخ أ٘( انعمذ ٔتمٛٛى نتشتٛة انثٛاَٙ انشسى اخَظشٚ استخذاو ًٚكٍ نزنك،. انشثكاخ
ٔانتمٛٛى  انتشتٛة خٕاسصيٛاخيٍ  20 ْزا انثسث ٚطثك رنك، عهٗ علأج. انخفٛح ٔانًعشفح خظائضان نهسظٕل عهٗ
 رنك، يٍ الأْى. انثذ٘ سشطاٌانًتعهّ ت اندُٛاخيٍ تعهٛى اٜنح نذساسح  ًَٕرخٍٛ نهدُٛاخ انٕساثٛح, زٛث تُغزٖ إنٗ 
ٔانتخهض يٍ  الألهٛحنضٚادج انعُٛاخ  ططُاعٛحتى اعتًاد اسهٕب طُاعح عُٛاخ ا ًُسشفحان انثٛاَاخ يشكهح عهٗ نهتغهة
 لتشذتى ا أخٛشا،. ّيتٕاصَ تٛاَاخ إنٗ انًتٕاصَح غٛش ثٛاَاخان يدًٕعح تسٕٚم أخم يٍتشكم عشٕائٙ انعُٛاخ انًفشطح 
اسهٕب خذٚذ فٙ ْزِ انذساسح نتمسٛٛى انثٛاَاخ ٔيٍ ثى تعهٛى ًَزخٙ اٜنح, ٔتى انتسمك يٍ لٕج ٔطسح انًُزخٍٛ يٍ 
  يماٚٛس. أستعحخلال زساب 
ٔ شثكح انتفاعم  ،انثشٔتٍٛ تفاعم شثكح انتعثٛش، شثكح عهٗ زذج كلا ًيٍ8 خاطٛح عشش أستعح تى استخشج نمذ8 النتائج
 سشطاٌ دُٛاختى استخذاو ْزِ انخظائض يٍ خلال ًَٕرخٍٛ يٍ تعهٛى اٜنّ نكتشاف الأًَاط انًتعهمح ت ثى،. انٕظٛفٙ
هتغهة عهٗ يشكهح انثٛاَاخ انًُسشفح لثم تعهٛى ًَٕرخٙ اٜنح تى استخذاو تمُٛح يٕاصَح انثٛاَاخ ن ،اندذٚش تانزكش .انثذ٘
تمُٛاخ يختهفح نتمٛٛى انخظائض انًستخشخح يٍ انشثكاخ  تاستخذاو. انثٕٛنٕخٛح انشثكاخ خًٛع ٔلذ تى فعم رنك فٙ
 iixx
 
انسٕٛٚح, تى انتٕطم إنٗ اٌ "انذسخح انًعٛاسٚح" أكثش انخظائض أًْٛح نكتشاف الأًَاط انًتعهمح تدُٛاخ سشطاٌ 
 انثذ٘.
 خُٛاخ نتسذٚذ ْايح تعتثش انتٙ انطٕتٕغشافٛح انًٛضاخ يٍ فشعٛح يدًٕعح ْزِ انذساسح تى انتعشف عهٗفٙ 8 الخاتمة
 ساعذتُا , ٔانتٙيتعًك تسهٛم نتطثٛك' انذسخح انًعٛاسٚح' تٕخّ انخظٕص عهٗ خاطٛح اعتًذَا ٔلذ. انثذ٘ سشطاٌ
  .انثذ٘ سشطاٌ يتعهمح تًشع لذ تكٌٕ تشكم كثٛش خُٛاخ ثلاثح تسذٚذ عهٗ
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1. CHAPTER 1 
INTRODUCTION 
1.1. Overview 
The ultimate goal of biologists is to understand the genetic bases of human diseases.  
Hence, the disease-gene association will prevent and provide proper therapeutic of 
diseases. For instance, Online Mendelian Inheritance in Man [1], the genetic association 
database [2], and other databases store phenotypic genes. These databases provide the 
"seed" genes of a certain disease, which might help to investigate further candidate genes. 
However, to understand and study new disease-genes association is a challenging task 
which requires laborious experiments.  Moreover, it is time-consuming for a researcher to 
genotype and phenotype large population to determine which sequence features are most 
related to specific phenotype. Therefore, different bio-statistical techniques have been 
proposed to predict disease-gene association. For instance, linkage mapping is a 
statistical approach that has been successful to find the genomic regions that are related to 
a disease [3]. It is widely known technique that might examine genetically well-
characterized populations, such as  to identify quantitative trait loci (QTL) that contain 
causal mutations [4]. However, the identified regions typically reveal hundreds of 
candidate disease-causing genes [3] which means to identify the actual disease genes 
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among the revealed candidate genes empirically it will still take a huge amount of time 
and effort.  
Although quantitative genetics methods had promising results, these approaches have 
problematic limitations. For instance, QTL technique could suffer from sampling biases 
[4]. In addition, several linkages mapping QTL studies lack the statistical power to 
reduce the defined causal loci, which go through the entire chromosomes population that 
contain hundreds of candidate gens [5]. Therefore, it is necessary to provide an 
alternative and complementary approach that could substitute quantitative genetics 
techniques. Such new techniques must be independent and bias-free inherent in 
quantitative genetics. Furthermore, a combination of graph theory (i.e. biology network) 
and computational intelligence techniques could be applied to model co-expression, PPIs, 
and functional genomics networks of the activities of genes (e.g. expression, interaction, 
etc.). These techniques could identify candidate genes that probably will be involved in a 
phenotypic outcome, thus, that would lead to new discoveries in phenotype-gene 
associations. 
The study of complex biological networks is a significant emerging field in a wide 
variety of disciplines, ranging from computer science, physics, and sociology, to biology. 
In the field of biomedicine and biology, there are a potential of research applications for 
network analysis. These include, drug development, personalized medicine, determining 
a gene's function, or phenotype-gene association studies. Furthermore, large and complex 
biological networks could be often represented using nodes and edges (i.e. nodes 
represent genes and edges represent interactions among genes). Such representation could 
be used to reveal significant hidden knowledge for further data analysis and pattern 
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extraction. The graph theory plays an important role in the interactive analysis to build up 
the question of "which genes are most important relatively to a particular gene or set of 
genes". However, biological networks are too complex and cannot be analyzed easily. 
Thus, these biological networks could be understood through the utilization of graph 
theory analysis approaches. The graph theory is well-known approach that has been 
inspired from the study of the social network problems [6] and could be utilized to study 
biological networks as well. More interestingly, graph theory could be used to compute 
the topological properties and extract hidden knowledge of complex biological networks. 
In this study, fourteen  different raking properties are computed (i.e. degree, closeness, 
betweeness, eigenvectors, within module z-score, k-step Markov, sub-graph, clustering 
coefficient, flow coefficient,  Katz status, coreness, structural holes, proximity and Bary-
center score). These topological properties have been extracted from co-expression, 
BioGrid PPIs, and functional protein interaction networks to rank the importance of 
individual genes relatively to others. Further, these aforementioned topological features 
are assessed in a hill-climbing feature selection to reveal the most significant sub-set 
topological features that provide best prediction rate.   
In this study, the extracted topological features out of complex biological networks 
are utilized as features to build automated models using machine learning.  The built 
models could be used to associate different kind of phenotypes (i.e. this study is 
investigating breast cancer genes). Prior the classification and due to the sever imbalance 
datasets; a SMOTE sampling technique is applied. Then, the balanced datasets are fed to 
two different classification models: Decision Tree Bagger (DTB) and RUSBoost. The 
two classifiers are implemented to predict breast cancer and non-breast cancer genes. 
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1.2. Motivation 
Prior to the development of high-throughput technologies, it was difficult to diagnose 
diseases. The diagnostic process was based heavily on the identification of symptoms. 
Obviously, these symptoms are common among different types of diseases. Interestingly, 
the completion of human genome project in April, 2003 
(http://www.genome.gov/11006943) opened the horizon to the informatics era. The 
genomic information abundance brought significant improvement in the way for diseases 
association. More specifically, a certain gene could be associated with a disease on 
interest. For instance, remarkable results achieved by proteomics (i.e. the large-scale of 
protein-protein interactions network) helped us to have a better understanding of protein 
functions as proteins are the essence of metabolic pathways of cells.   
The disease-gene association in wet-labs is a challenging process for biologists. 
Thousands of genes need to be analyzed, which is not feasible to be conducted in labs. 
Thus, the high-throughput technologies are utilized to narrow potential candidate genes 
for a disease of interest. A combination of graph theory (i.e. biology network) and 
computational intelligence techniques from machine learning tools can help us to better 
analyze and identify gene functions.  Functional networks and machine learning 
emerging techniques could reveal significant phenotypic genes in remarkable manner of 
time.  
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1.3. Objectives and Goals 
The main objective and goals of the proposed study is to develop new models capable 
of predicting genes, and validate pre-exiting genes that are associated or related to a 
certain phenotype using biological networks data with the latest available Artificial 
Intelligence (AI) and data mining techniques. These objectives will be achieved through 
the following millstones: 
1. Providing gene function predictions to prioritize genes most likely to be relative or 
associated with breast cancer through biological networks analysis. 
2. Utilizing a protein-protein interactions network and gene expression network in order 
to investigate breast cancer phenotypic genes. 
3. To utilize integrated complex network (functional network) and identify disease 
specific genes.  
4. To apply a network approach and machine learning methods in order to identify 
breast cancer phenotype.  
5. To provide insight of how well topological properties of different biological 
networks could help identifying biomarkers utilizing, functional genomics, protein-
protein interactions network and co-expression datasets. 
1.4. Contribution 
This thesis work provides an efficient and reliable approach with high accuracy rate 
to solve the problem of disease-gene association. The thesis contribution could be 
summarized as follows: 
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1. Implementation of fourteen different centrality measures and ranking algorithms. 
These ranking algorithms could be categorized as follows: local and global 
centrality measures. More specifically, we predict the phenotypic genes based on 
a collection of topological features, rather than using a single topological feature 
at a time.  
2. Applying various features selection: 1) Pearson correlation coefficients (PCCs) 
and 2) hill-climbing feature selection to identify the most significant topological 
features that provide best prediction rate.  
3. Building different classification models that allow biologist to predict breast 
cancer genes.  
4. Proposing our co-cross validation scheme to provide a generalized classification 
performance.  
5. Implementation of a SMOTE sampling technique to balance the datasets. In 
return, enhance the classification performance.  
6. Utilizing three publicly datasets (functional genomics network, protein-protein 
interactions network, and co-expression network) to extract different topological 
features.  
1.5. Outline 
The rest of the thesis is organized as follows: Chapter 2 provides a background to the 
biological, graph theory terminologies, and the proposed ranking and scoring algorithm 
for the genes in the biological networks. 
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Chapter 3 provides review of previously published work related to disease-gene 
association. 
Chapter 4 presents how to overcome the problem of unbalanced datasets, the 
randomization of the biological networks, and more importantly, the implemented 
classifiers in this study. 
Chapter 5 presents the experimental datasets and a description of how the 
classification models would be evaluated. 
Chapter 6 presents the Experimental Results and discussion of the proposed 
computed scoring algorithms. Finally Chapter 7 concludes the thesis work and highlights 
the future work directions. 
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2. CHAPTER 2 
BACKGROUND 
 
2.1. Biological Terminology 
Cell biology is the essential component of living organisms, which is the structural, 
functional and biological unit of such organisms. More specifically, a cell contains 
further smaller ingredients of DNA, RNA, proteins, and metabolites, which are a part of a 
tissue.  Collections of different tissue form the organs of an organism. More importantly, 
the organisms are evolving, which results to form relationships among elements in the 
organism. The relationship among these elements is a place for interest to study. These 
relationships could be presented as a graph (network), in which the organism's elements 
are the vertices (proteins, genes, DNA, RNA), and the relationships among these 
elements could be presented as edges (interactions among the elements). Very well-
known types of biological networks at the molecular level are known as gene regulation 
networks, signal transduction networks, protein interaction networks, and metabolic 
networks. An example of a biological network is shown in  Fig. 1.  
 
Fig. 1.  Example of a biological network that is generated randomly. 
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2.1.1 Basic Biological Ingredient 
The desoxyribonucleic acid (DNA) (see  Fig. 2. )  stores the information of an 
organism ( Fig. 3. ). DNA is viewed as a double coiled ladder (double helix), which 
consists of two sugar phosphates in the backbones. The backbones are enclosed by pairs 
of nucleotide bases (i.e. adenine, cytosine, guanine, and thymine (A, C, G, and T). It is 
worth noting that the nucleotide A pairs only with T, and C pairs only with G. On other 
hand, ribonucleic acid (RNA) could be viewed as a single helix ( Fig. 2. ), which the 
backbone consist of   Phosphate and ribose sugar, and backbone consists of the following 
four bases: adenine, guanine, uracil, and cytosine (A, G, U, and C) 
 
Fig. 2.  DNA and RNA structure. 
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Fig. 3.  Information processing staring from genes until research metabolites in 
cells. The picture is obtained from the book by Junker, Björn H., and Falk 
Schreiber [7]. 
The process of information transition from DNA to proteins is known as gene 
expression ( Fig. 3. ). This process could be explained in two main folds: 
1. Transcription: is a sophisticated, highly regulated process. A protein complex 
contains RNA polymerase opens the DNA helix, reads one strand and generates 
the corresponding RNA like a scheme. The corresponding generated RNA is 
named as transcript ( Fig. 3. ) 
2. Translation: is the final stage of protein generation from generated RNA. RNA 
goes through a process which is called slicing, such that the introns (noncoding 
regions) are removed and only the exons (coding regions) stays. In translation, 
amino acid chains are generated from the (spliced) RNA by the   ribosomes. The 
RNA information is read in triplets (codons), such that there are         
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combinations. These combinations are utilized to code 20 amino acids (i.e.one 
codon might represent more than one amino acid), additionally one start codon 
and three stop codons.  
2.1.2 Cell Biology 
Organism could have one of two cells types. Prokaryotes, e.g., bacteria, which are 
only single cells and cannot be subdivided. Prokaryotes genomes (i.e. the whole of the 
genes) are formed as a single circular chromosome (i.e. the structure of DNA, RNA, 
protein that could be found in the cells). On the other hand, eukaryotes cells are more 
sophisticated ( Fig. 4. ). 
 
Fig. 4.  Elucidation of an animal cell with some organelles. The picture is obtained 
from the book by Junker, Björn H., and Falk Schreiber [7]. 
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The genome of eukaryotes cells is structured on many chromosomes inside the nucleus. 
Each chromosome contains two chromatids ( Fig. 5. ). It means on the gene level, a 
eukaryotic cell has at least two copies of every gene. In addition, majority of organism 
cells contains two sets of chromosomes, one from each parent. 
 
Fig. 5.  Illustration of eukaryotes chromosome: 1) chromatid – one of the two 
identical parts of chromosome, 2) Centromere – where the two chromatids intersect, 
3) short arm, 4) long arm. 
2.1.3 System Biology 
The field of biology is evolving which will shift into accurate science with the 
availability of high-throughput technologies and bioinformatics techniques. The massive 
13 
 
and wealthy datasets that are generated out of high-through technologies shifted the 
attention rather than dealing with an individual genes, to deal with a collection of genes. 
This field of biology is called "systems biology: a new field in biology that meant to 
understand and make sense of a biological system at a system-level". Interestingly, 
system biology will enable the understanding of totality of biological systems by 
visualization, modeling, and the prediction of the behavior of a system's components, 
sub-components, and interaction within components.  
As promising as the field sounds, but the abundance of the –omics datasets that are 
generated from high-throughput technologies make it difficult to make sense of these 
datasets. To model these datasets and might generate hypothesis to be studied, network 
(graph) analysis could be used, as it will be described in the following section.  
2.2. Graph Theoretic Terminology 
This section introduces the fundamental concepts of graph theory that will be used in 
this thesis work. The mathematical formulation will be described as provided in the 
literature [7-9].  
2.2.1. Undirected Graph 
A graph  is usually defined as a pair of      , such that   contains the set of 
vertices, which represent the nodes and E contains the set of edges, representing the 
interaction between the nodes. Furthermore,   could be defined as follows   
{    |       , which is a connection between the two nodes    and  . So, we could say 
that the two nodes   and   are neighbors. In addition, the two nodes could have a multi-
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edge connection, such that they are two or more edges having the same endpoints.  A 
multi-edges connection is an important feature, such that the two nodes are connected by 
more than on link. In such case, each connection might convey different type of 
information. 
2.2.2. Directed Graph 
A directed graph could be defined as follows,            , such that the function   
maps each member of   to an ordered pair of nodes in    . The ordered pairs are directed 
edges, known as arcs or arrows. Furthermore, the directed graph is asymmetric, such that 
if an edge           has a direction from  to  , then it is not necessary there be an edge 
having a direction from   to  . 
2.2.3. Weighted Graph 
The weighted graph could be defined as          , where   is the set of nodes and 
  is the set of edges between the vertices     {      |         . In this case there will 
be a weight function to assign a score for every edge:       , where   denotes the set 
of all real numbers. Usually the weight     that is assigned to an edge has a meaning of 
how relevant two nodes   and   are, so, the higher the weight, the higher the relevance 
might be. 
2.2.4. Data Structure 
The main data structure that has been used to store the network graph representations 
is adjacency matrix. For a given graph         , then the adjacency matrix 
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representation size will be | | | |       . However, matrix A contains entries either of 
1's or 0's, such that         if   and      or           otherwise. Such that, 
   (
       
   
       
), where     | |. In the case of a weighted graph, the entry   
         if   and      or           otherwise. Furthermore, for an undirected graph, 
the adjacency matrix is symmetric for the reason that         . However, the previously 
mentioned rule is not applicable to directed graphs, for the reason that the upper and 
lower triangular parts of the matrix shows the direction of the edges. Moreover, the space 
complexity of the adjacency matrix is   | |  .Thus, it is highly preferred to be used with 
dense graphs rather than the sparse graphs. In addition, for an all-against-all symmetric 
data set, then either the upper or the lower triangular part of the matrix is needed. This 
will then reduce the amount of space complexity to be   | | . However, such data 
structure will be well suited with the cluttered networks that have high density 
connections between the elements. Finally, for the case of the fully connected graph, such 
that all nodes are connected to each other, then an adjacency matrix is highly suggested.  
2.2.5. Graph (Network) Properties 
Graph theory could play important role in assessing each node of the network, and 
could retrieve valuable properties and features that could provide insight about the 
internal structure of biological networks. In the following, a brief description of the 
fundamental properties that could be used to analyze a network is as follows: 
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2.2.5.1. Graph Density 
The graph density helps to reveal the likelihood of a graph, whether it is spare or 
dense (i.e. depends of the number of links for every node set). This could be computed as 
follows:          
  | |
| | | |   
. Moreover, for a spare graph would be a graph meets the 
following parameters, | |    | |  and       , or otherwise when | |   | |.On the 
other hand, a dense graph would meet the following parameter (i.e. a graph where 
| |   | | ). 
2.2.5.2. Average Shortest Path  
The average path length of a given network is defined as the average number of edges 
between nodes. The average path length must be traversed in the shortest path between 
any two nodes.  Furthermore, it can be computed as    
 
       
∑ ∑          
 
   
 
    
where          is the minimum distance between nodes   and  . 
It is also worth mentioning that the most well-known two algorithms for computing 
the shortest paths are Dijkstra‟s greedy algorithm [10] and Floyd‟s dynamic algorithm 
[11]. 
2.2.5.3. Diameter  
The graph diameter could be found by computing the longest shortest path within a 
graph. Thus, the diameter is defined                
   . 
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Fig. 6.  (a) An original graph to illustrate the purpose for different centrality 
measures. (b)  If we remove A, the network will be disconnected into two sub-
graphs. Then, is node A an important vertex?. (c)  If node B1 is removed then the 
graph will be scatted into disconnected components. Therefore, an identification of 
important node is non-deterministic. The picture is obtained from the book by 
Junker, Björn H., and Falk Schreiber [7]. 
2.3. Centrality Measures and Node Ranking 
This section provides a mathematical description of different raking theories [7-9, 
12], such that how is a certain node could be raked or sorted according to its position in 
the biological network. More importantly, the obtained score for every vertex is 
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meaningless, unless it is associated with the properly asked question. For example, in the 
biological networks, how would the detection of central or intermediate nodes affect the 
topology of the network. It is important to state a goal of finding the central nodes. 
However, a question could be to find the molecules that are really central, but more 
importantly, they are participating in a biological pathway and have a crucial role in 
signal transduction. Furthermore, a centrality measure can only capture a portion of the 
important elements within a network as illustrated in  Fig. 6. Therefore, different 
centrality measures are developed with different interpretation [13-16]. More specifically, 
in this thesis we compute fourteen centrality measures for every gene in the biological 
network.  
1. Degree (DC) centrality: 
   reveals that the highly significant nodes participate in a large number of 
interactions. For a given node  , the degree centrality is defined as        = the  number 
incident edges. For directed graphs, an in-degree          and an out-degree          
can be defined, such that,        , represents the number of arcs going toward a node  , 
but           represents the number of  arcs going out of a node  . Furthermore, those 
nodes which are highly connected are called hubs. The scale free networks tend to have 
hubs. The removal of such highly connected nodes will have an effect upon network 
topology. The biological networks are robust against random removal of hubs. On the 
other hand, their removal may cause system failure [17, 18]. 
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2. Closeness Centrality (     ): 
      elucidates the significant nodes that can communicate quickly with other 
nodes of the network. For a vertex     in graph          it is defined by the 
following equation: 
          
 
∑          
| |
   
 
(1)  
Where          is the length of the shortest path between two vertices   and  . For a node 
with a high        will require a minimum number of steps to pass information 
originating from itself to other nodes in the network. It also indicates how a change in a 
node affects other nodes in the network.  
3. Betweeness Centrality     : 
   indicates the ease by which certain vertices can monitor communications between 
other vertices. Without the existence of such nodes that monitor communication, then 
there will be no way for other nodes to communicate. For a vertex     in graph 
         it is defined by the following equation: 
        ∑ ∑
      
   
              
 
(2)  
      are the number of shortest paths between two vertices   and   that pass through 
vertex    If   and   are not connected, 
      
   
  . It shows how influential a node is over 
the information flow in a network. A node having high    potentially plays an important 
role in the network by controlling the flow of interactions. 
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4. Eigenvector Centrality (EC): 
The eigenvector centrality expresses the centrality of a node as dependent on the 
centralities of its directly connected neighboring nodes. A node is highly ranked if and 
only if that node is connected to important neighbors. For an undirected graph    
       and   is the adjacency matrix of network  . Then, the eigenvector centrality is 
the eigenvector       of the largest eigenvalue       in absolute value, such that could be 
obtained from the following system of equations: 
      ⃗⃗ ⃗⃗ ⃗⃗  ⃗       ⃗⃗ ⃗⃗ ⃗⃗  ⃗ (3)  
5. K-Step Markov (KSM): 
The K-Step Markov technique calculates the relative probability that the system will 
spend some time at any particular node, such that, it is given the start set of roots   and 
shall end after   steps. The author whit et al.[19], demonstrates that the number of steps 
  manage the bias distribution toward the specified roots  . In addition, as   gets larger 
the steady distribution coverage to PageRank results. However, for a graph         
contains vertices        and edges          Next, Let      be the probability to reach 
  from   in one step,so this probability is the weight of the edge between   and  . Then, 
let      be the set of neighbor vertices of  . After that, the probabilities are constrained 
by the following equation. 
 
∑     
   
      
   
(4)  
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Furthermore, a random walk is defined as a walk that starts at a particular vertex and 
traverses the graph based on the    . Then, K-Step Markov centrality is the probability 
with which a random walk of length   brings a system to a particular vertex [19]. For 
vertex , k-Step Markov (     is defined by the following equation. 
             
    (5)  
Where   is an initial probability distribution of the vertices, , and   is the adjacency 
matrix of   containing the transition probabilities. Finally, in this study we consider k to 
be 6. 
6. Subgraph centrality (   : 
    ranking nodes according to the number of times a given vertex participates in 
different connected subgraphs of a network  [15]. A subgraph is a closed walk that starts 
and ends at the same vertex.   , weighted according to the length of the closed walks. 
The weight of a closed walk decreases with increase in its length. For a vertex   in 
undirected graph          , and   is the adjacency matrix of  . Then, the subgraph 
centrality for a node that has the length of a close walk   is computed as follows: 
       ∑
      
  
 
   
 (6)  
7. Clustering Coefficient (   : 
   measures the degree of cohesiveness in a given graph. For a given vertex, it is 
defined as the ratio of actual number of adjacent edges    to the maximum number of 
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possible edges. This gives the probability that two vertices with a common neighbor are 
connected: 
       
   
      
 (7)  
Furthermore,    measures the edges ratio of a certain node to the total possible number of 
edges, i.e.,         .    values range in the interval of        . Thus, as the local 
clustering coefficient of a certain node gets closer to 1, then it is more likely that node is 
highly ranked. 
8. Flow Coefficient (FC):  
The clustering coefficient of a node, as shown above, is calculated as the number of 
all existing connections between the node‟s neighbors divided by the number of all 
possible such connections. However, in analogy to the clustering coefficient, the Flow 
Coefficient [20] is defined as the number of all paths of length 2 linking neighbors of a 
central node that pass through the node, divided by the total numbers of all possible such 
paths. Furthermore, the flow coefficient allows estimating the capacity of a node to 
conduct information flow between its neighboring nodes, thus, the flow coefficient, is a 
measure of „„local centrality‟‟. It is calculated as the number of actual paths of length 2 
divided by the number of all possible paths of length 2 that traverse a central node. Hub 
regions that act as bridges between different communities of nodes are likely to exhibit 
small clustering coefficients and large flow coefficients. 
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9. Katz Status Index (   ) centrality: 
    ranks a node as highly important if a large number of vertices are connected to 
it. Both direct and indirect neighbors of a vertex contribute to its importance. For a graph 
with adjacency matrix  ,     is defined by the following equation: 
    ⃗⃗⃗⃗⃗⃗⃗⃗                ⃗  (8)  
 is a scaling factor that is less than the reciprocal of the absolute value of the largest 
eigenvalue of A (     |    |⁄ ).  
 the transpose of  ,   is an identity vector,  ⃗  is a 
vector of ones. 
10. Node Coreness (NC): 
Node coreness [21] measures the set of nodes that are highly and mutually 
interconnected which are known as network core. For a binary network, the k-core is the 
largest subgraph comprising nodes of degree at least k, and is derived by recursively 
removing off nodes with degree lower than k until none remain. Each node is then 
assigned a core number, which is defined as the largest k such that the node is still 
contained in the k-core. The k-core decomposition is applied on binary connections. 
11. Within Module Z-score (WMZ): 
The within module z-score [22] measures how nodes are relatively related within a 
module. Moreover, modules could be organized in different ways, such that some 
modules could be totally centralized with one or few nodes connected to all others. 
However, some modules could be totally decentralized, with all nodes having similar 
connectiveness. Furthermore, the nodes with similar roles are anticipated to have similar 
relative within-module connectivity. If    is the number of links of node    to other nodes 
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in its module  ,  ̅   is the average of   over all the nodes in   , and     is the standard 
deviation of   in     hen: 
     
      ̅  
   
 (9)  
this is the so-called z-score. The within-module degree z-score measures how well-
connected node   is to other nodes in the module. 
12. The Burt’s measure of constraint(Structural Holes (SH)): 
Structural holes[23]measures the degree to which an individual has exclusive 
exchange relations to otherwise disconnected partners and groups. Individuals with more 
structural holes are positioned for entrepreneurial action as they can control the flow 
between people on opposite sides of structural holes. The Burt‟s measure of constraint 
could be found using the following equation: 
          ∑       
          
   
(10)  
Where    is the adjacency matrix of   containing the transition probabilities. Given the 
    matrix, the indirect constraint (      ), could be obtained with the 2-step path 
distance. 
13. Proximity Prestige (PP): 
Proximity prestige [24] is used to determine what is known as the node‟s influence 
domain. Such that the influence domain of a node could be defined as the set of nodes 
who are both directly and indirectly linked to that node. This set includes those nodes that 
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are reachable to node  .If there exists a path then these two nodes are called reachable 
from one another. The influence domain for node   includes all nodes whose entries in the 
 -th column of a distance matrix are finite.  The number of nodes in the influence domain 
for a node   is denoted by  . Furthermore, the proximity prestige could be measured as the 
ratio of the proportion of nodes which can reach  to the average path length of these 
nodes from . 
         
        
∑     
  
          
 
(11)  
Where  is the number of nodes in the influence domain of node   ,  is the total number of 
nodes in the graph and        is the geodesic distance that node  is from node  . 
14. Bary-Center Score (BCS): 
BaryCenter score[19] ranks each node of the graph depending on the total shortest 
path of the node. It computes the shortest path distances for each node in the graph, and a 
score will be assigned for each node based on the lengths of the shortest paths that go 
through the node. Moreover, the highly central nodes in a connected component tend to 
have smaller overall shortest paths. On the other hand, the 'peripheral' nodes on the 
network tend to have larger overall shortest paths. 
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3. CHAPTER 3 
LITERATURE REVIEW 
The identification of gene-phenotype association has been studied in many different 
aspects. In literature, there are studies which utilize the protein-protein interactions (PPIs) 
[25] and gene expression [25] solely without the integration of prior knowledge (i.e. 
Gene Ontology (GO)) or integration with different data types. More recently, high-
throughput technologies like microarrays and, most recently, next generation sequencing 
have increasingly generated massive datasets. These datasets were shown to examine 
false positive interactions [26, 27].Thus, several authors have proposed different 
techniques that some utilizing supervised machine learning and others are utilizing un-
supervised machine learning for the purpose of different data type integration. Moreover, 
the following review several works that has published of how the aforementioned 
problem tackled to investigate disease-causing genes. 
3.1. Gene Expression  
The gene expression datasets have been used extensively for the purpose of diseases-
causing gene. There are many studies utilizing gene expression in different perspectives. 
Such that, the genes expression profiles are used as is and fed as features to the 
classification problems, and some researches might filter or apply feature selection prior 
the classification. More specifically, this section reviews published work based on the use 
of gene expression profiles. The reviewed work is further categorized into: 1) Machine 
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Learning-Based Disease-Gene Association and 2) Co-expression Based Disease Gene-
Association.  
3.1.1. Machine Learning-Based Disease-Gene Association 
This section reviews published work based on the machine learning techniques to 
predict the disease-gene association. Automated models could be built for the purpose of 
predicting the phenotypic genes based on the raw gene expression profiles. For instance, 
one of the pioneer studies published by Furey et al. [28]proposed support vector 
machines (SVMs) for the purpose of analyzing tissue samples of microarray data. The 
performed analysis has two folds, firstly, the classification of the tissue samples, and 
scanning of the data for the mislabeled tissue results. Moreover, the Furey et al. approach 
was evaluated using ovarian cancer tissues, normal ovarian tissues, and other normal 
tissues. For each tissue that consists of expression results for 97,802cDNAs.  
Furthermore, the proposed approach was able to reveal mislabeled tissue samples, after 
fixing these mislabeled samples and removing the outliers, the SVMs achieved perfect 
classification. However, the confidence level was not high.  
Ramaswamy et al. [29] proposed to utilizes 218  tumor samples, spanning 14 
common tumor types, and 90 normal tissue samples to oligonucleotide microarray gene 
expression analysis. The expression levels of 16,063 genes and expressed sequence tags 
are employed for the evaluation of accuracy of the multiclass classifier. Ramaswamy‟s et 
al. study implements SVMs to distinguish the tumor and normal samples. The 
classification model was able to achieve an accuracy rate of 78%. A similar study which 
is done by Lee et al. [30] proposed the use of the extended support vector machines [31], 
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which will be used to  classify gene expression data of multi-category cancer problems. 
The Multi-category SVM was evaluated using two gene expression data sets, first of 
which leukemia data that comes with three classes [32]. The other dataset is the small 
round blue cell tumors of childhood data [33] which is a four classes problem. The 
resultant of this study showed comparable classification accuracy to the other 
classification methods.  
There are different studies, which implement different classification models for gene 
expression datasets. For instance, Wei et al. [34] proposed an automated model to 
classify patients and to which risk group of neuroblastoma they belong. This study 
utilizes gene expression profiling from cDNA microarrays that contains 42,578 clones. 
Moreover, an artificial neural networks classification model is adapted to build a 
predictor of survival for each individual patient with neuroblastoma. Additionally; 
principle component analysis (PCA) is applied and revealed that neuroblastoma tumors 
exhibited inherent prognostic specific gene expression profiles. In addition, expression 
levels of 37,920 good-quality clones are fed to an artificial neural network-based 
prognosis prediction; however, the achieved accuracy rate is 88%. Further analysis is 
applied using an artificial neural network-based gene minimization technique that reveals 
19 genes, including 2 prognostic markers that have been reported before. They are 
MYCNand CD44, which correctly predicted outcome for 98% of these patients. Theses 
identified 19 genes able to classify the Children's Oncology Group-stratified high-risk 
patients into two subgroups according to their survival status (P = 0.0005). 
A different study that has been published by Xia et al. [35], who developed an 
ensemble decision approach that can do gene mining tasks. Xia et al. has utilized two 
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publicly available datasets for analysis purposes, which are colon data [36] and leukemia 
data [32]. However, the analysis has revealed 20 significant colon cancer genes, and 23 
significant molecular signatures for refining the acute leukemia phenotype. The identified 
genes are verified using biological experiments or by alternative analysis approaches.  
Dettling et al. [37] proposed to modify and extend the boosting classifiers for 
microarray expression data that comes from several tissue or cancer types. In addition, 
feature selection is applied and LogitBoost is used, which is integrated with several 
approaches for binary problems. The Dettling et al. algorithm was evaluated using six 
real and one simulated gene expression datasets. This approach does not implement 
sophisticated tuning or kernel selection and provides directly class membership 
probabilities. 
Previously reviewed research studies one classification model which lacks the 
comparison of results with other different classification models. Guthke et al. [38] 
studied the use of supervised and unsupervised clustering techniques and machine 
learning algorithms for automated model relationships between gene expression data and 
gene functions of microorganism Escherichia coli [39]. Moreover, the Guthke et al. study 
utilized pre-selected subset of 265 genes (which belong to 3 functional groups) However, 
the functions have been predicted with an accuracy rate of 63-71% by various data 
mining methods. For example, some of the machine learning algorithms that were 
presented in this paper are: K-means clustering, Kohonen‟s self-organizing maps (SOM), 
Eisen‟s hierarchical clustering and Quinlan‟s C4.5 decision tree induction algorithm. 
Moreover, the Guthke et al. study introduced the use of the fuzzy approach for gene 
expression data analysis. Such that, it has investigated the used of the fuzzy-C-means 
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algorithm (FCM), the Gustafson-Kessel algorithm for unsupervised clustering, and the 
Adaptive Neuro-Fuzzy Inference System (ANFIS) for the purpose of the functional 
classification of E. coli genes.  
Moreover, Pirooznia et al. [40] also studied different classification models to 
investigate different diseases through the gene expression datasets. The implemented 
classification models are SVM, Neural Networks, MLP Neural Networks, Bayesian, 
Decision Tree, and Random Forest. In addition, some of the unsupervised machines 
learning models used include: K-means, Density Based Clustering (DBC), and 
Expectation Maximization (EM) clustering. Furthermore, the gene expression data 
dimension was reduced using different feature section algorithms for comparison 
purposes, which include: support vector machine recursive feature elimination (SVM-
RFE), Chi Squared, and Correlation based Feature Selection (CFS) [41]. More 
importantly, K-fold cross-validation is utilized for the evaluation purposes. For each case 
mentioned previously, eight different binary (two class) microarray datasets are used to 
investigate the following diseases: Lymphoma, Breast Cancer, Colon Cancer, Lung 
Cancer, Adenocarcinoma, Lymphoma, Melanoma, and Ovarian Cancer. 
3.1.2. Co-expression Based Disease-Gene Association 
The gene expression profiles could be used to reveal the co-expression links based on 
the correlation between each pair of gene expression. More interestingly then, gene 
expressions could be modeled as a network. In this case, the disease-causing genes could 
be studied in more depth, rather than studying a gene at a time. Hence, it is possible to 
study genes that interact with each other and might rank a certain gene to reveal its 
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susceptibility to cause a disease of interest. More importantly, the ability to study the 
gene neighbors for the possibility that they might cause the same disease of interest. For 
instance, Lee et al.[42], who introduced a large-scale analysis of mRNA co-expression 
utilizing 60 large human data sets contains a total of 3924 microarrays. The Lee et al. 
study explored the pairs of genes that were reliably co-expressed (based on the 
correlation of their expression profiles) in multiple datasets. Moreover, a high-confidence 
network was built consisting of 8805 genes linked by 220, 649 “co-expression links” that 
are observed on at least three datasets. This study has revealed that the co-expression in 
multiple datasets is correlated with functional relatedness. Additionally, the large body of 
accumulated microarray data can be exploited to increase the reliability of inference 
about gene function. 
Ruan et al.[43] proposed a general co-expression network-based technique that 
allows analysis of genes and samples obtained from microarray datasets. The Ruan et al. 
technique has a rank-based network construction method, a parameter-free module 
discovery algorithm, and a reference network-based metric for module evaluation. This 
study has utilized different datasets for evaluation purposes, i.e. yeast, Arabidopsis and 
human cancer microarray.  
A more sophisticated technique was proposed by de Matos Simoes et al. [44] to infer 
casual gene regulatory networks from large-scale gene expression data and a proposed 
method called BC3NET. The proposed method is an ensemble-based on the bagging of a 
C3NET algorithm. Furthermore, the BC3NET algorithm matches with the Bayesian 
technique but with non-informative priors. The proposed algorithm was evaluated using 
simulated and biological gene expression data from S. cerevisiae. 
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Interestingly, Zhu et al. [45] proposed a network-based SVM with hinge loss function 
to classify a binary class problem through the utilization of the penalty term from   - 
norm, which will be applied to pairwise gene neighbors for prediction and gene selection. 
The Zhu et al. algorithm was evaluated using low and high-dimensional data, 
additionally; two real microarrays are used for evaluation. The proposed algorithm is able 
to achieve a similar or higher prediction accuracy compared with the standard and the    
penalized SVMs.  
In addition, Wu et al. [46] proposed the utilization of a machine learning model for 
the identification of prognostic biomarkers in cancer gene expression data sets, utilizing 
modules inferred from a highly reliable gene functional interaction network [47]. The 
proposed work could be divided into two folds: 1) module discovery, and 2) module 
validation. For the model discovery, a breast cancer tissue microarray is used [48], but for 
the validation module, four different independent breast cancer microarray expression 
datasets are used [25]. The Wu et al. approach algorithm build-up on the functional 
interaction (FI) network to find out the prognostic signatures as it is un-weighted and is 
not for a certain tissue of phenotype. However, the Pearson correlation coefficients 
(PCCs) is calculated among all functional interaction pairs in the gene expression dataset, 
and then the PCCs weights are assigned to the edges of the FI network. In this case, the 
un-weighed graph is converted to be weighed for a particular disease. Then,  the Markov 
clustering (MCL) [49] is applied to cluster the weighted network into a series of gene 
interaction modules.  Moreover, this approach has revealed a 31-gene signature 
associated with patient survival for the breast cancer application.  The signature is 
repeated through the 5 independent gene expression studies. Furthermore, this study also 
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has revealed a 75-gene that is signature associated to the patient survival for the 
application of ovarian cancer. 
Most recently, Zhang et al.[50]  proposed a network-based Cox regression model (i.e. 
it is called Net-Cox).  The proposed model is meant to investigate the gene expression 
signatures (i.e. these signatures probably participate in the results of death or repetition in 
ovarian cancer medication). The analysis of the co-expression and the prior knowledge of 
gene functional relations are utilized to construct the relations between gene expressions 
as a gene relation network. Furthermore, the Net-Cox model is then used to study the co-
expression or functional relation within the gene expression features for survival 
prediction outcome in ovarian cancer treatment. The Zhang et al. study does not solely 
depend on the univariate Cox regression [25].Additionally, it utilizes the co-expression 
and functional information to build up the gene networks. More importantly, the network-
based analysis will assist in identifying sub-network signatures and help in the prognosis 
of survival in ovarian cancer therapy. However, Net-Cox detected a signature gene, 
FBN1, which was validated as a biomarker for predicting early recurrence in 
platinumsensitive ovarian cancer patients in a laboratory. 
Table 1 Literature Overview of studies utilizing Gene Expression Profiles 
Author Method Tackled Problem 
Machine Learning-Based Disease-Gene Association 
Furey et al. 2000 SVM Ovarian cancer 
34 
 
Author Method Tackled Problem 
Ramaswamyet al. 
2001 
SVM 
Tumor and 
Oligonucleotide 
Guthke et al.2002 
Supervised and unsupervised machine 
learning techniques 
Reveal relationship 
between gene 
expression and gene 
functions 
Lee et al.2003 SVM 
Leukemia and Round 
blue cell tumor 
Dettling et al.2003 Boosting classifier 
Leukemia, Colon, 
Estrogen and Nodal, 
Lymphoma 
Wei et al. 2004 Neural Networks/PCA 
Neuroblastoma and 
Colon 
Xia et al. 2004 Ensamble decision technique Acute Leukemia 
Pirooznia et al.2008 
Supervised and unpupervised machine 
learning techniques/ Different features 
slection are used 
Lymphoma, Breast 
Cancer, Colon 
Cancer, Lung 
Cancer, 
Adenocarcinoma, 
Lymphoma, 
Melanoma, and 
Ovarian Cancer 
Co-expression Based Disease-Gene Association 
Zhu et al. 2009 
Network-based SVM (Using biological 
prior knowledge to build SVM) 
Parkinson's disease 
and Breast cancer 
Ruanet al. 2010 Rank-based network construction 
Co-expression links 
prediction 
De Matos Simoes et 
al. 2012 
BC3NET: A tool to infere gene network 
from gene expression 
Yeast and simulated 
gene expression are 
used to validate 
BC3NET 
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Author Method Tackled Problem 
Wu et al. 2012 
Markov clustering scheme is used to 
reveal funtional group 
Breast cancer 
biomarkers 
prediction 
Zhang et al. 2013 Network-based Cox regression model Ovarian cancer 
3.2. PPIs Literature Review 
Protein networks have been used for great analysis to reveal molecular evolution, and 
the analysis of protein functions and identification of new functions. They have been used 
for validating existing diseases and, more importantly, revealing new diseases. The 
protein network simply could be presented as graph that contains set of nodes and edges. 
The nodes represent the genes and the edges represent the interaction between these 
genes. For example, protein-protein interactions (PPIs) networks could be easily seen as 
undirected graphs, such that, the nodes are the proteins, and if the proteins are physically 
known to interact then they are connected by an undirected edge. More specifically, this 
section reviews published work based on the use of PPIs networks. The reviewed work is 
further categorized into: 1) Guilt by Association and 2) Kernel Models-based disease-
gene association. 
3.2.1. Guilt by Association  
The guilt by association is based on the proximity concept, such that the analysis of 
genes those are neighbor to known disease genes (seeds). For instance, Goh et al. [51] 
assumed that if genes  are neighbors in the network of a disease-causing gene, there is 
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possibility they yield the same or a similar disease. Furthermore, the networks models 
have been used in different research. For instance, Navlakha et al. [52] proposed to use 
the PPIs network to investigate disease-gene association. Navlakha et al. has utilized 
several published computational methods (i.e. direct network neighbors [53], graph 
summarization [54], markov clustering [55], semi-supervised graph Partitioning  [56], 
random walks [57], and network flow [58]) to rank and associate genes to a disease of 
interest. This study has revealed that the random-walk technique outperforms the 
clustering and neighborhood techniques. Furthermore, most methods propose predictions 
that are not made by other methods. In addition, the combination of the previously 
mentioned methods results in an optimal decision. Navlakha et al. investigated the diffuse 
topological distribution of disease-related proteins which negatively affects the quality of 
the prediction. Thus, it has the ability to reveal diseases that are adjustable to network-
based prediction. However, the algorithms were evaluated using Human Protein 
Reference Database (HPRD) [59]. 
Vanunu et al. [60]  built a gene prioritization network-based  model to predict a genes 
and proteins complex that are related to a certain disease. The proposed algorithm is 
called PRINCE (PRIoritizatioN and Complex Elucidation).This approach combines the 
protein-protein interactions (PPIs) information with disease of similarity metrics and then 
the interactions will be scored to reveal how strongly those proteins associated with a 
certain phenotype of interest. The score methodology is done as follows: 1) the utilization 
of seeds of genes that have the same phenotype or similar ones, 2) the seed genes 
repeatedly propagates the flow to the network neighbors. The aforementioned two steps 
will reveal the strength-of-association (i.e. the neighbor nodes are assigned similar 
37 
 
values), such that, each protein propagates the flow received in the prior iteration to its 
neighbor. Each protein has an assigned score (i.e. computed by the amount of flow it 
has).This score is used in the integration with a PPI network for the prediction of the 
protein complex that might be involved in the given disease. Furthermore, there are three 
diseases are studied (Prostate Cancer, Alzheimer Disease, and Non-insulin-dependent 
Diabetes Mellitus (Type 2)).The phenotypic genes are collected from Online Mendelian 
Inheritance in Man (OMIM) [61]. In addition, the used PPIs network contains 9998 
proteins and 41072 interactions. These PPIs are obtained from three large scale 
experiments [25], additionally,  Human Protein Reference Database (HPRD) [62] is used. 
Finally, the proposed algorithm was tested using a leave-one-out cross-validation setting. 
3.2.2. Kernel Models-based disease-gene association  
Kernels models based on the utilization of extracted features out of the datasets. 
Then, these features are applied for the purpose of disease-gene prediction. For instance, 
Lage et al. [63] developed a systematics, large-scale investigation of the human protein 
complexes including products that are implicated in several categories of human diseases 
to create the phenome-interactome network. However, this study is constructed through 
the integration of controlled interactions of human proteins with a computationally 
validated phenotype similarity score. This will allow the prediction of the previously 
unknown complexes that might be associated with a disease. In addition, Lage et al. 
implemented a Bayesian predictor model where a phenomic ranking of protein 
complexes likened to human disease are utilized for building such a model. This model is 
able to predict 298 out of 669 linkage intervals correctly rank the known disease-causing 
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protein as the top candidate. In addition, the Bayesian model in 870 intervals with no 
identified disease-causing genes was able to reveal candidates implicated in different 
disorders. 
Reyes et al. [64] proposed to tackle the problem of prediction of protein-protein 
interactions (PPIs) when integrating different types of biological information, such that 
two proteins are classified whether they do or do not interact utilizing different machine 
classification models. The formation of the data yields to two essential problems that can 
affect the results: 1) the imbalance class problem (i.e. the positive samples that really 
interact smaller than the negative samples), and 2) the selection of negative examples. 
Reyes et al has used the one-class classification (OCC) to predict the PPI, the advantage 
of OCC utilizing only one class to generate the predictive model that is independent of 
the type of negative examples chosen, which will have the ability to handle the 
imbalanced class problem. 
Finally, it is obvious the concept of PPIs utilization to reveal the disease-causing-
genes and the assumption of using 'seeds' of known genes that are associated to 
phenotype of interested has rapidly been used to validate and tackle new diseases.  
Table 2 Literature Overview of studies utilizing PPIs Network 
Author Method Tackled Problem 
Kernel Models-based disease-gene association 
Lage et al. 2007 Bayesian predictor model 
Retinitis pigmentosa, 
epithelial ovarian 
cancer, inflammatory 
bowel disease, 
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Author Method Tackled Problem 
Kernel Models-based disease-gene association 
amyotrophic lateral 
sclerosis, Alzheimer 
disease, type 2 
diabetes and 
coronary heart 
disease 
Reyes et al. 2007 One class classification model 
Predict PPIs of a 
network 
Guilty By Association 
Navlakha et al. 2010 
Direct network neighbor, graph 
summarization, Markov clustering, 
semi-supervised graph Partitioning, and 
random walks, and network flow. 
Identify family-based 
diseases 
Vanunu et al. 2010 Prioritization and Complex Elucidation 
Prostate Cancer, 
Alzheimer Disease, 
and Non-insulin-
dependent Diabetes 
Mellitus (Type 2) 
3.3. Genomic Data Integration Literature Review 
There is a new era of the high-throughput data utilization, rather than investigating 
every single 'omics' data solely, are integrated to draw a bigger view of available 
genomics, transcriptomics, and proteomics datasets. Furthermore, the integration to such 
data will provide a complete description model to study and analyze a certain biological 
phenomena. It will also validate existing results, even more to predict new findings that 
are not found in previous naïve models. Furthermore, a review paper has been published 
by Georgia et al.[65] which reviews the different methodologies that have been known in 
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the literature of how the different data types possibly could be integrated (i.e. the data 
integration could be done thorough Bayesian models, Kernel models and SVM, or Guilt-
by-association models). In this thesis, we adopted the same categorization. 
3.3.1. Guilt by Association  
The guilt by association is based on the proximity concept, such that the analysis of 
genes those are neighbor to known disease genes (seeds). For instance, Savage et al. [66] 
proposed a method that integrates gene expression and transcription factor binding 
(ChIP-chip) data that allows direct inferring transcriptional modules (TMs). This method 
expands the   hierarchical Dirichlet process mixture model to allow data fusion on a gene-
by-gene basis. Moreover, this method encodes the co-expression and co-regulation that 
are not needed to be equivalent. Thus, the genes are not expected to group in the same 
way in both datasets. In addition, this method allows revealing the subset of genes that 
share same structure of transcriptional modules in both datasets. 
Singh-Blom et al. [67] proposed two methods that relies on functional gene 
associations and phenotype-gene associations in model organisms for the purpose of 
disease-gene association. Two methods, the Katz measure method, and the second one, 
CATAPULT (Combining dATaAcross species using Positive-Unlabeled Learning 
Techniques) is a supervised machine learning technique that utilizes a biased support 
vector machine, which features are derived from walks in a heterogeneous gene-trait 
network. The evaluation of the Singh-Blom et al. algorithm is done utilizing two data 
sets, OMIM phenotypes and drug-target interactions. This study has revealed that the 
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Katz measure is better at identifying associations between traits and poorly studied genes; 
whereas, CATAPULT is better suited to correctly identifying gene-trait associations overall. 
3.3.2. Bayesian Models  
The Bayesian models could be further subdivided into: 1) Bayesian network models, 
2) Bayesian classification models. The Bayesian network is constructed using Directed 
Acyclic Graph (DAG), such that each node (variable) shows how it conditions on other 
variables. More importantly, the Bayesian network could integrate datasets that are 
dissimilar. For instance, Huttenhower et al.[68] proposed a scalable Bayesian framework 
for predicting functional relationships from integrated microarray datasets, which is 
called the Microarray Experiment Functional Integration Technology (MEFIT). The 
MEFIT framework predicts the functional relationships within the context of specific 
biological processes. This study has integrated 40 Saccharomyces cerevisiae microarray 
datasets spanning 712 unique conditions using MEFIT. Furthermore, the test of this 
method based on 110 biological functions utilized from GO biological process ontology, 
showed a 5% or greater performance increase for 54 functions, with a 5% or more 
decrease in performance in only two functions. 
Huttenhower et al. [69] developed a Sleipnir C++ library that implements multiple 
machine learning and data manipulation algorithms with a focus on heterogeneous data 
integration that could handle large biological data collections. Sleipnir has the ability to 
process microarray, functional ontology mining, clustering, Bayesian learning and 
inferences and support vector machine that could be applied to heterogeneous data on a 
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large scale. Moreover, this library has the advantage of being integrated with other 
computational systems.  
Nguyen et al. [70] proposed a toolbox for learning a globally optimal dynamic 
Bayesian network (DBN)  structure from the gene expression data sets. Nguyen et al 
utilized the mutual information test (MIT) scoring system; such that the globally optimal 
learning DBN is achieved in polynomial time.  
Wang et al. [71] proposed the identification of functional modules out of protein-
protein interaction (PPI).The proposed technique is called the PPI-based Bayesian 
Models (PPIBM). The PPIBM approach integrates both the gene expression data analysis 
and clustering of protein-protein interactions. Furthermore, PPIBM utilizes the Bayesian 
model, which uses its base protein-protein interactions given as a part of input. 
Chang et al. [72] proposed the use of a Bayesian network-based technique for the 
purpose of a single-nucleotide polymorphism (SNP) and expression microarray data 
integration. The integrated network models the SNP-gene interactions through the 
phenotype centric network. However, Chang et al. consists of two parts, variable 
selection and network learning. The learnt network elucidates how functionally 
dependent SNPs and how genes effects each other. In addition, the learnt network could 
be utilized for the purpose of predicting phenotypes. Moreover, this study has 
investigated the pediatric acute lymphoblastic leukemia dataset. 
Yuanfang et al. [4] proposed an approach that overcomes the limitations of the 
quantitative genetics techniques through the application of functional genomics. The 
proposed algorithm integrates the genome-wide functional relationship network and 
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SVM. The functional relationship network was first constructed utilizing the laboratory 
mouse through the integration of multiple different data types, excluding phenotype and 
disease data to avoid contamination in the evaluation process. The data was integrated 
utilizing Gene Ontology as a gold standard and using an established Bayesian pipeline 
[73]. Moreover, the constructed network was fed into SVM for the prediction of related 
phenotypes. The proposed algorithm is evaluated through predicting genes associated 
with each of the 1,157 diverse phenotype ontology terms. This study has investigated 
bone mineral density (BMD), a phenotype related to an osteoporotic fracture, and 
revealed two genes (i.e. Timp2 and Abcg8) that are related to bone density defects, which 
are not identified in other statistical methods (i.e. genome-wide association studies / 
quantitative trait loci). 
Wu et al. [47] developed  a functional interaction, an (FI) network that combines both 
curated interactions from Reactome [74], other pathway databases, such as Panther [75] 
CellMap, NCI Pathway Interaction Database, and KEGG, additionally, un-curated 
pairwise relationships. This study utilizes collected data from physical PPIs in human and 
model organisms, gene co-expression data, protein domain-domain interactions, proteins 
interactions generated from text mining, and Gene Ontology annotations. The Wu et al. 
technique utilizes the naïve Bayes classifier (NBC) to reveal the high FIs from non-
functional pairwise relationships, to neglect the false positives.  The built protein 
functional interaction network (i.e. combines the curated pathways with non-curated 
source of information) covering close to 50% of the human proteome, then using this 
network to investigate two Glioblastoma multiforme (GBM) data sets and projecting the 
cancer candidate genes onto the FI network. 
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3.3.3. Kernel Models and SVM 
Kernels models and SVM based on the utilization of extracted features out of the 
datasets. Then, these features are applied for the purpose of integration and disease-gene 
prediction. For instance, Yu et al.[76] investigated biological systems through the 
integration of both the human protein  reference database [59],the protein-protein 
interaction (PPI) network and the gene expression omnibus [77] data to study lung 
cancer. Furthermore, A SVM classification model was implemented to predict the PPIs. 
Most recently, Qian et al. [78] studied the Multiple Sclerosis disease using two gene 
expression datasets and the HPRD protein-protein interaction for the integration process. 
The Qian et al.  technique was divided into four steps: 1) the inference of the gene states 
are done by Hidden Markov Model (HMM)/Gaussian Mixture Model (GMM) hybrid 
model, 2) the extraction of the bi-clusters out of the gene state sequences, 3) assigning a 
score for each bi-cluster, dependent on its genes' connection in the PPI network, and 4) 
K-nearest neighbor classification model is trained and then the SVM classification model 
is utilized on the collection of K-nearest neighbors. 
Finally, in literature [25] has investigated that the pairwise interactions could be 
incomplete (false negatives) and contains noise (false positives). For that reason, many 
studies have been published toward integrating several data types and knowledge to 
provide highly reliable and efficient one single probabilistic integrated model, such that, 
this model is able to identify disease markers optimally [79]. 
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Table 3 Literature Overview of studies utilizing Functional Genomics Network 
Author Method Tackled Problem 
Guilt By Association  
Savage et al. 2010 Hierarchical Dirichlet process mixture 
Gene expression and 
transcription factor 
integration 
Sigh-Blom et al. 2013 Katz and CATAPULT 
OMIM phenotypes 
and drug-target 
interactions 
prediction 
Bayesian Models 
Huttenhoweret al. 
2006 
Bayesian framework for predicting 
functional relations  
Integrating various 
Saccharomyces 
cerevisiae microarray 
datasets 
Huttenhoweret al. 
2008 
Sleipnir C++ library  
Allow integration of 
various of datasets 
using: 1) Bayesian 
classification model 
or 2) SVM 
Yuanfang et al. 2010 
Byesian based tehcnique to integrate 
different datasets/SVM for 
classification 
Bone mineral density 
Wu et al. 2010 
Naïve Bayes classifier to integrate 
varous datasets 
Study glioblastoma-
multiforme brain 
tumor 
Nguyen et al. 2011 Bayesian network construction 
A tool for learning 
globally optimal 
dynamic Bayesian 
network structure 
Chang et al. 2011 
Bayesian network-based technique to 
integrate SNP and gene expression 
Pediatric acute 
lymphoblastic 
leukemia 
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Author Method Tackled Problem 
Wang et al.2012 PPI-based Bayesian integration 
Integrates gene 
expression and PPIs 
network 
Kernel Models and SVM 
Yu et al. 2013 
SVM-based classification model to 
reveal PPIs  
Lung cancer 
prediction 
Qian et al. 2013 K-nearest/SVM 
Multiple Sclerosis 
disease prediction 
3.4. Our Proposed Method 
In this study, we extract fourteen topological features. These features are very well-
known in literature which are used to study genes either in local or global manner in the 
biological or social networks. More importantly, these topological features (or raking 
algorithms) are typically used to prioritize candidate genes based on one raking algorithm 
at a time. However, this study attempts to use fourteen ranking algorithm at once through 
the utilization of efficient and reliable classification models. Furthermore, the 
classification performance is enhanced using a SMOTE sampling technique to overcome 
the imbalance datasets problem that comes in nature in such biological networks. The 
classification performance is validates using a novel co-cross validation technique. 
Finally, the classification models power is verified utilizing three publicly datasets 
(functional genomics network, protein-protein interactions network, and co-expression 
network). 
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Fig. 7.  A summary of the research procedure. 
 Fig. 7. shows the work summary that has been adopted in this research: 
1. We start-off with a biological network as shown in upper left corner. Our 
contribution, we combine fourteen topological features instead of using a single 
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48 
 
topological feature. These fourteen topological features are computed for every 
gene in the biological network. 
2. We balance the datasets using a SMOTE sampling technique to enhance the 
classification performance. 
3. We proposed a novel co-cross-validation technique that has not been used in the 
literature, to provide a generalized performance for the classification models. 
4. Our contribution is extended in the form of a feature space that is fed to different 
classification models to discriminate breast cancer and non-breast cancer genes. 
5. The classification models are built to predict breast cancer in the following 
scenarios: a) one features at a time, b) applying hill-climbing to find the most 
significant sub-set of topological features that increases the classification 
performance and c) applying Pearson's correlation coefficients features selection. 
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4. CHAPTER 4 
METHODOLOGY 
The complex biological networks could be represented as graphs. Such that, a node 
represents a gene, and the interactions between genes could be represented by links. In 
the literature, several ranking algorithms are developed to rank a certain node to its 
position in the graph. Some algorithms rank a certain gene depending on its direct 
neighbors. Others ranking algorithms rank a certain node globally (i.e. all nodes are 
considered). In this study, three different datasets (i.e. co-expression, PPIs, and functional 
genomic networks) are utilized to examine fourteen ranking algorithms. The computed 
scores for each gene are then fed into two different classification models to discriminate a 
disease of interest (i.e. breast cancer). Due to the high imbalance, SMOTE sampling 
technique is adopted. 
4.1. Genomic Data Integration Methodology 
This study has utilized Wu et al. publicly available integrated datasets of several 
types (i.e. gene expression, PPIs, Gene Ontology, and Domain Interaction). There is an 
urgent need to apply integration of multiple datasets of different types, such that 
knowledge from different resources is gained to construct a more reliable network. The 
problem of using a single dataset is that the pairwise networks do not necessarily provide 
fully 100% true positive interaction between two genes of proteins. For instance, the 
yeast two-hybrid approach might indicate that two proteins might physically interact 
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without indicting that this interaction constitutes a part of a biological meaningful 
pathway in the living organism [47].  Moreover, there might be pairwise interaction 
datasets that may have a high false positive [26, 27]. In this section, we provide an 
overview of Wu et al. integration approach which could be summarized in the following 
three items.   
1. Transforming pairwise interactions into probable functional interactions 
The aforementioned problem of false positive could be resolve through the utilization 
of a pathway-based inference on the high-throughput functional data sets, such that the 
utilization of pathway databases will reveal a clean pairwise that are functionally related. 
Wuet al.[47] goal is to integrate both high-coverage, unreliable pairwise datasets with the 
low-coverage, highly reliable pathways to create a pathway informed data analysis for 
high-throughput analysis. 
The first step to achieving this goal is that a functional interaction (FI) network is 
constructed that integrates a curated interaction from Reactome [74] and other pathway 
databases (i.e. Panther[75], CellMap[80], NCI-Nature[81], NCI-BioCarta[81], and 
KEGG[82]), with un-curated pairwise relationships that are collected from physical PPIs 
in human and model organisms, gene co-expression data, protein domain-domain 
interactions, protein generated from text mining, and Gene Ontology annotations. The 
Wu et al. approach makes use of the naïve Bayes classifier (NBC) to discriminate high-
likelihood FIs from non-functional pairwise relationships. 
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2. Construction and training of a functional interaction classifier 
The essential goal is to establish a network of protein functional relationships that 
shows functionally significant molecular events in cellular pathways. Most PPIs   
interaction databases are categorized as physically interactions and there is no clear proof 
that these interactions are involved in biomedical events. Furthermore, even other protein 
pairwise relationships have similar problems. An NBC [83] is implemented which scores 
the probability that two proteins are functionally related in a pathway event (i.e. if the 
probability greater or equal to 0.5).  
Obviously the pathway databases are far richer than the binary PPIs and other 
pairwise relationships in terms of contents.  Thus, Wu et al. has developed a relationship, 
called „functional interaction‟, which defines a functional interaction as one in which two 
proteins are involved in the same biochemical reaction as an input, catalyst, activator, or 
inhibitor, or as two members of the same protein complex. The aforementioned definition 
is used to obtain the positive training sets from Reactome pathways for NBC. However, 
the NBC must be trained with both positive and negative samples. More importantly, the 
lack of knowledge that two proteins are not known to interact does not mean that these 
two protein are not interacting. Wu et  al. adopted Zhange et al. [84] to create negative 
samples using random pairs selected from proteins in the Reactome FI set (in other 
words, using random pairs from the positive samples).  
3. Merging the NBC with pathway data to create an extended FI network 
An extended FI network is constructed with high protein and gene coverage through 
the combination of FIs predicted from the trained NBC with the annotated FIs extracted 
from the pathway databases (i.e. the pathway databases are: Reactome [74], Panther [75], 
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CellMap [80], NCI-Nature [81], NCI-BioCarta [81], and KEGG[82]). For the purpose of 
increasing the coverage of the FI network, the interactions between human transcription 
factors and their targets from the TRED database are imported [85]. Furthermore, the 
result in an extended FI network consisting of 10,956 proteins and 209,988 FIs. 
4.2. SMOTE: Synthetic Minority Over-sampling TEchnique 
This study investigates highly imbalanced datasets (i.e. one category is far more than 
the other category). To enhance the classification performance the SMOTE sampling 
technique was used in this study, which was proposed by Chawla et al. [86].SMOTE has 
the advantage of combining in formed oversampling of the minority class with random 
under-sampling of the majority class. However, SMOTE is a sampling approach that 
could be used to overcome the problem of imbalance datasets. It over-samples the 
minority class by creating synthetic samples rather than over-sampling with replacements 
(i.e. that the positive (minority) samples are over-sampled with replacement to match the 
number of negative (majority) samples). However, it operates in "feature space" rather 
than "data space". Such that, the minority class is over-sampled by taking each minority 
class sample and generating synthetic samples along the line segments joining any or all 
of the k minority class nearest neighbors. The neighbors from the k nearest neighbors are 
randomly selected, and that is based on the amount of over-sampling needed. 
SMOTE sampling technique computation should go as follows: 
1. For each minority Sample: 
◦ Find its k-nearest minority neighbors. 
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◦ Randomly select n of these neighbors. 
◦ Randomly generate synthetic samples along the lines joining the minority 
sample and its n selected neighbors. 
2. For instance: 
◦ Select a minority sample.  
◦ Take the difference between minority sample under consideration and its 
nearest neighbor. 
◦ Multiply this difference by a random number between 0 and 1, and  
◦ Add the resultant difference to minority sample under consideration (i.e. 
this will be the synthetic sample).  
SMOTE was implemented in R using the ' DMwR' package [87]. It is worth 
mentioning that SMOTE was implemented with the following parameters: 1) the k-
nearest neighbor is equal to 5 for every case scenario in this study, 2) to sample the breast 
cancer featuring the over sampling percentage = 400 and under sampling percentage = 
125.  
4.3. Biological Network Randomization 
The biological network that has been utilized in this study was randomized based on 
the Maslov et al. [88] technique. The procedure rewires the connections of a given 
complex network, more importantly, conserving the connectiveness (keeping the degree of 
each vertex constant). Firstly, the algorithm uses a conventional procedure to perform the 
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network randomization randomly choosing a pair of edges A→B and C→D. Secondly, the 
randomly chosen edges are rewired in the following manner, A becomes connected to D 
and C becomes connected to B. Furthermore, if it happens that one or both of these new 
links already exist in the network, then this step is canceled and a new pair of edges will 
be chosen. This restriction will result an out of a network that prevents the appearance of 
multiple edges connecting the same pair of nodes. Thirdly, a repetition of the previous 
rewiring procedure will provide a randomized network of the original network. Finally, 
the randomization of a large complex network will help to reveal significant topological 
patterns in a network. Such pattern might be over (or under) represented in the real 
network compared to the randomized network.  Fig. 8. illustrate the biological network 
randomization methodology: 1) Select randomly pair of edges and rewire.  Such that, the 
new re-wiring should not exist in the current network. 2) Results in a null model 
(randomized network) of a given complex network. Such that, the degree of direct 
neighbors is preserved. 3) The randomized model could be used to identify the over- 
under- represented pattern in the real network. 
 
Fig. 8.  Biological Network Randomization 
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4.4. Implemented Classifiers 
In this study, there are mainly two stages to investigate whether a gene is related to a 
certain disease (i.e. breast cancer). Firstly, a graph theory is employed for feature 
extraction based on the network centrality measures and node raking as described earlier, 
and then SMOTE is applied to balance the minority class. Secondly, the performance of 
different classifiers for the prediction of different crucial diseases are analyzed (i.e. breast 
cancer). In particular, this study considers two classification models. First, to start off 
with, the decision tree bagger (DTB) [89-91] and RUSBoost [92] are both  tested with a 
different growing number of trees.  However, the used classifiers are implemented in 
Matlab [93]. Each model will be described briefly as follows. 
4.4.1. Decision Trees Bagger 
Bagging, which is also known as "bootstrap aggregation," is one of ensemble learning. 
The weak leaner decision tree will bag a specific dataset through generating many 
bootstrap replicas of the dataset, and the decision trees will be grown on these replicas. 
The bootstrap replica could be sampled randomly choosing from N observations out of N 
with replacement, where N is the dataset size. Furthermore, the average of the predictions 
from individual trees will give the predicted output of the trained ensemble. 
The bagging technique is employed by training learners on resampled versions of the 
data which are often facilitated by bootstrapping observations, such that, N out of N 
observations with replacements are chosen for every new learner. Furthermore, the 
accuracy of the bagged trees could be improved, such that the tree in the ensemble could 
randomly choose the predictors for the decision splits.  
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Finally, the implemented minimal leaf sizes of the bagged trees are set to be 1. Thus, 
the trees grown (i.e. this study applied exhaustive growing trees starting from 50 up to 
750, such that the increment pointer is 50 trees and then the best number of grown trees is 
chosen) with such a minimal leaf size tend to be very deep. More importantly, this setting 
is closer to be the optimal for the predictive power of an ensemble, but time consuming. 
Another important parameter is the number of predictors that are chosen randomly for 
every decision split. However, the parameter is determined as the square root of the 
number of the predictors. 
4.4.2. RUSBoost 
RUS is an acronym for Random Under sampling. It is meant to deal with imbalanced 
datasets effectively. Firstly, the algorithm is developed to take   observations to be the 
number of members in the class with the fewest members in the training data. These 
observations will be handled as the basic population for sampling. Furthermore, the 
majority classes are under sampled by taking only N observations of every class. 
The RUSBoost ensemble is constructed with an optimal name-value pair. Called Ratio-
To-Smallest, it provides a vector of K values, with each value representing the multiple of 
N to sample for the associated class. For instance, if the minority class contains only N = 
100 members and the vector K =       then it could be interpreted that each weak learner 
has 200 members, 300 members and 400 members for the class 1, 2 and 3, respectively. 
Finally, if the Ratio-To-Smallest generates a value that is greater than the number of 
members in a specific class, then the RUSBoost samples the members with a replacement. 
Else and RUSBoost samples members without a replacement. 
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This study fixes one parameter of the RUSBoost that is the minimal leaf size, trees are 
set to be a default value = 1. On the other hands, the trees grown in this study are growing 
trees starting from 50 up to 750, such that the increment pointer is 50 trees. Then, among 
the grown set of trees, the one that is gives the best classification performance is selected. 
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5. CHAPTER 5 
EXPERIMENTS 
5.1. Experimental Data 
A biologist generates massive datasets using high-throughput technologies (i.e. 
genomics, proteomics, or transcriptomics [65]). For instance, proteomics might provide 
for protein-protein interactions (PPIs) [25]through the yeast, the two-hybrid method or 
mass spectrometry.  However, with PPIs, processing two or more genes are considered to 
be physically interacting. The datasets of PPIs could be viewed as a network, such that 
each gene in this network is represented using a node, and the interaction between genes 
represented using links. Using transcriptomics technologies, for instance, microarray 
could provide a gene expression profiling [25], such that, gene expression profiling 
measures the expression values of genes. Furthermore, this study utilizes three types of 
datasets. These datasets are BioGrid Homo sapiens PPIs [94], gene expression which 
made publicly available by Hedenfalk et al. [95], and an integrated functional protein 
network which made publicly available by Wu et. al. [96]. Prior to utilizing these 
networks, the common genes across these three datasets are obtained, such that, the 
common number of genes is 1,235.Based on this common number all three datasets are 
filtered to have the same size for all three networks.  
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5.1.1. Gene Expression Datasets 
This study utilizes gene expression profiles of breast cancer for comparing and 
evaluating the classification and prediction purposes against the integrated genomic 
network of Wu et al. [96] and the BioGrid PPI. Firstly, the breast cancer gene expression 
profiles that has been utilized are obtained from Hedenfalk et al. [95], which consists 
originally of 3,226 genes and 22 gene expression profiles of patients that have breast 
cancer.  The Hedenfalk et al. gene expression profiles are filtered according to the 
common genes (i.e. 1,235 genes).  
The gene expression profiles are used to construct a co-expression network. The 
network construction is based on Ruan et al. [43]. The Ruan et al. approach is a rank-
based network construction technique. Furthermore, the constructed co-expression 
network was randomized based on the Maslov et al. method. However, the resulted 
networks properties are shown in Table 4. 
Table 4 Co-Expression Network Properties 
Dataset Proteins Interactions 
Average 
Degree 
Density 
Co-expression 
Nerwork 
1,235 05,051 46.0 1.140 
Randomized 
Co-expression 
Nerwork 
1,235 05,051 46.0 1.140 
5.1.2. Proteins-Proteins Interactions (PPIs) Networks 
For further analysis, this study utilizes single PPIs of Homo sapiens to extract the 
topological features that have been described above and then fed into the classification 
models, i.e., these classification results will be reasoned against the Wu et al. integrated 
genomic network and the Hedenfalk et al. gene expression datasets classification results. 
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The datasets of PPIs are considered as a network. However, the nodes represent proteins 
and edges represent interactions among proteins. The PPI data of homo sapiens that were 
obtained from the BioGrid database has a version code of “BIOGRID-ORGANISM-
Homo_sapiens-3.2.96”, which consists of 14,850 proteins and 169,166 interactions [94]. 
More importantly, the BioGrid PPIs is pre-processed, such that the proteins that are not 
found among the common genes (i.e. 1,235 genes), then are removed from the BioGrid 
PPIs network. In addition, the filtered PPIs network, which consists only of 1,235 genes 
was randomized based on the Maslov et al. method. However, the resulted network 
properties are shown in Table 5. 
Table 5 PPIs Network Properties 
Dataset Proteins Interactions 
Average 
Degree 
Density 
PPIs Nerwork 1,235 04,023 07.7 1.104 
Randomized 
PPIs Nerwork 
1,235 01,250 04.7 1.102 
5.1.3. Integrated Genomics Network 
The third dataset of this utilized study is made publicly available by Wu et al.[96]. The 
constructed functional protein biological network has the advantages of binding both the 
high-coverage and unreliable pairwise datasets with the low-coverage, highly reliable 
pathways to make a pathway-informed data analysis system for high-throughput data 
analysis. However, the integration of both “high-coverage, unreliable pairwise” with “low-
coverage, highly reliable pathways” datasets yield a functional interaction (FI) network. 
This FI network was constructed using curated interactions by experts and un-curated 
pairwise relationships (including protein-protein interactions in human and model 
organisms, genes co-expression data, protein domain-domain interactions, protein domain 
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extracted from text mining and Gene Ontology annotations). More importantly, the FI 
network covers approximately 50% of the human entire set of proteins. Moreover, the 
proposed scoring system that is used by Wu et al.is a naïve Bayes classifier machine 
learning model. The score is an indication of the probability that a protein pairwise 
relationship reflects a function pathway event (refer to ch# 4, section  4.1 for the integration 
methodology). Furthermore, Wu et al. FI network was filtered to contain genes that match 
the common genes across the other two utilized datasets (i.e. gene expression and PPIs). In 
addition, the filtered FI network, which consists of only 1,235 genes, was randomized 
based on the Maslov et al. method. However, the resulted networks properties are shown 
in Table 6. 
Table 6 FI Network Properties 
Dataset Proteins Interactions 
Average 
Degree 
Density 
FI Nerwork 1,235 6,004 00.3 1.100 
Randomized FI 
Nerwork 
1,235 00,212 40.5 1.106 
5.1.4. Breast Cancer Genes 
Breast cancer genes and the ones that are related to these diseases are annotated and 
could be found in several public databases. This study has utilized several databases to 
extract the phenotypic genes that are related to breast cancer. Such that, the genetic 
association database (GAD) [2], The Mammalian Phenotype (MP) [97], The Human 
Phenotype Ontology [98] are made used of to extract genes that related to breast cancer.  
Due to the severe unbalanced datasets, a sampling technique was utilized SMOTE to 
balance the data of these extracted features. This yielded consistently positive and 
negative samples across the three datasets (i.e. gene expression, BioGrid PPIs, and FI 
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network). Such that, there 615 positive samples and 615 negative samples for the breast 
cancer.  
5.2. Co-Cross Validation 
The performance of each of the classifiers used in this thesis is generalized based on 
the use of cross-validation (CV) approach. CV is a well-known testing methodology that 
provides some insight on how well the system is able to classify using various 
combinations of testing and training data sets. The performance of phenotypic genes 
outcome prediction is measure by systematically excluding some data instances during the 
training process and testing the trained model using the excluded instances. However, we 
propose a novel technique based on the usual CV scheme, such that we have chosen a 5-
folds CV scheme, where each time 4-folds are used to create another 5-fold to train and 
test certain models of the classifier, the best model is selected based on the averaged 
values of: F-Measure, AUC, and Geometric-Mean. The model that has been chosen is 
based on the averaged three values then it is tested using the 1-left-out fold from the 
original 5-folds. The process is repeated to cover all the dataset as a testing dataset. It is 
worth mentioning that we used only 5-fold co-cross validation because of the large 
number of samples. Hence, the division of the datasets will create sufficient number of 
sample for trains, and sufficient number of samples for testing.  
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Fig. 9.  Proposed co-cross validation 
 Fig. 9. shows the layout of our proposed co-cross validation scheme. The progress of 
the co-cross validation goes as follows: 
1. At first stage, we create a 5-fold; out of these 5-folds we select 4-folds to create 
other 5-folds. 
2. At the second stage, we used the created new 5-folds to train and test the system: 
a. Use 4-folds for training and the left fold for testing. 
b. Repeat this process 5-time, such that at each iteration  new fold is used for 
testing (i.e. at first iteration fold one is used for testing and other four folds 
are used for training, at second iteration use the second fold for testing and 
other remaining folds for training, and so on). 
c. The classification performance is reported 5-time. Hence the average is 
taken. 
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d.  The best model that is chosen from second phase is based on the averaged 
values of F-Measure, AUC, and Geometric-Mean.  
3. The best model that has been chosen in the second phase will be used to test the 
classifier using the left fold from first stage.  
4. This process is repeated 5-time at stage one (i.e. the classification performance is 
reported 5-time; hence the average values are taken). 
5.3. Performance Evaluation 
Clinical research often investigates the statistical relationship between symptoms (or 
test results) and the presence of a disease. When significant associations are found, it is 
useful to express the data in ways which are clinically relevant. Thus, to evaluate the 
performances of the different classifiers models, the following performance metrics are 
used in this thesis. 
Let: 
FP = false positives: Represents the number of wrongly predicted positive samples. 
FN = false negatives: Represents the number of wrongly predicted negative samples. 
TP = true positives: Represents the number of correctly predicted positive samples. 
TN = true negatives: Represents the number of correctly predicted negative samples. 
The aforementioned four counting (i.e. FP, FN, TP, and TN) could be illustrated using 
the confusion matrix in Table 7.  
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Table 7 Confusion Matrix 
 
Predict Number of Negative 
samples 
Predict Number of Positive 
samples 
Actual Number of Negative 
samples 
TN FP 
Actual Number of Positive 
samples 
FN TP 
The following are definitions of the metrics that have been computed to evaluate each 
classifier performance. They are accuracy, F-measure, area under ROC curve, and 
geometric mean. Additional definitions, such as sensitivity, specificity, and positive 
predictive value are included, because the other metrics that are used in this thesis are 
dependent on those.  
1) Accuracy (ACC).Accuracy is one of the widely used performance metrics to 
evaluate a classifier. ACC is defined as all samples that are classified correctly 
over the total number of samples available (N). 
       
     
 
 (12)  
2) Sensitivity (SN). Sensitivity refers to the proportion of cancerous genes which 
are correctly predicted as cancerous and total cancerous genes. 
 
      
  
     
 (13)  
3) Specificity (SP). Specificity refers to the proportion of non-cancerous genes 
which are correctly eliminated and total non-cancerous gens. 
 
      
  
     
 (14)  
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4) Positive predictive value (PPV). Positive predictive value is the proportion of 
cancerous genes in the prediction which are correctly predicted as cancerous. 
 
       
  
     
 (15)  
5) F-measure (F). F-measure is the harmonic means of sensitivity and positive 
predictive value, which is defined as 
 
    
        
      
 (16)  
6) Area Under ROC plots[99]: Performances of each of the classifiers were 
computed using AUC (area under receiver operating characteristic: ROC curves). 
The ROC plot space is a one-unit square, which the highest obtained AUC value 
that could be 1, meaning perfect ordering. However, in ROC graphs with a 0.5 
AUC value, this represents random guessing, and values that smaller than 0.5 are 
not realistic as they can be negated by changing the decision criteria of the 
classifier. More importantly, the AUC value of a particular classifier could be 
viewed as the probability that a classifier will rank a randomly chosen positive 
instance higher than a randomly chosen negative instance. 
7) Geometric mean (Gm). Geometric mean has been introduced in [100]  to 
overcome the problem that is associated with accuracy metric in unbalanced 
dataset learning. 
       √      (17)  
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5.4. Hill-Climbing Feature Selection Technique 
The classification performance can be enhanced through choosing a combination of 
important features that represent maximal separation between the classes [101]. In this 
thesis, we applied a hill-climbing feature selection algorithm. This algorithm initially 
selects the most influential features from the dataset and then repetitively adds feature to 
the selected feature set that positively improves the classification results or provides the 
least reduction in classification performances. The steps of the algorithm are as follows: 
1. Initialize the select feature set   as an empty set.  
2. Compute the classification performance for each of the individual features   
paired with  . 
3. Select the feature       for which the best classification performance is achieved 
and add the feature to selected feature set  . 
4. Repeat steps 2 and 3 until there is no remaining feature to be added to  . 
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CHAPTER 6 
RESULTS AND DISCUSSION 
In this study, three datasets are utilized (i.e. co-expression network, BioGrid PPIs 
network, and FI network) to extract fourteen network topological features to predict breast 
cancer genes. These features are fed to two classifiers (i.e. Decision tree bagger (DTB) 
and  RUSBoost) which are implemented based on growing trees of multiple of 50 trees 
staring from 50 trees up to 750 trees. Prior the classification and due to the severe 
imbalance between positive and negative samples, a SMOTE sampling technique is used, 
which resulted in a standard number of samples (i.e. 615 positive and negative samples). 
Furthermore, to validate the classification performance, we propose our co-cross 
validation, which in this study is implemented with a 5-fold, as described earlier. Co-cross 
validation technique is effective and efficient scheme to avoid the classifier over-fitting. 
In this study, 1) we study the significance of the extracted 14 topological features from 
every individual biological networks. 2) Then, we study the most influential identified 
topological feature, and study its ability to reveal biological significant phenomena, in 
term of identifying the most central genes that are related to breast cancer.   
6.1. Classification Performance Significance based on the Proposed 
Extracted Features  
In this study, we construct a number of classification models to provide a wide view of 
the significant fourteen topological features and their ability to predict the phenotypic 
genes correctly and with high performance rates. More specifically, we find the 
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classification performance using: 1) one feature at a time, 2) using sub-set of selected 
topological features using Hill-Climbing Feature Selection, and 3) using sub-set of 
selected topological features using Pearson correlation coefficients (PCCs) features 
selection. 
6.1.1. Classification Performance using One Feature at a Time 
In this section, we show the classification performance for each topological feature to 
predict the breast cancer and non-breast cancer genes using three complex biological 
networks, i.e., co-expression, BioGrid PPIs, and FI networks (results are shown in Table 8 
- Table 10). Table 8 shows the classification results for the two classification models (i.e. 
DTB and RUSBoost) while adopting the extracted features from the co-expression 
network. We notice that within module Z-score (WMZ) topological feature provides the 
best classification results among the 14 topological features (i.e. DTB and RUSBoost 
achieve an accuracy rate of 81% (approx.), F-measure rate of 0.84, AUC rate of 0.81, and 
Geometric-Mean rate 0.80 while using only WMZ feature). 
 On the other hand, we observe that using node corness (NC) feature of co-expression 
network achieves the lowest classification performance among other topological features 
while classifying the datasets using DTB and RUSBoot to predict breast cancer (i.e. the 
accuracy rate of  55% (approx.), F-measure rate of 0.21, AUC  rate of 0.55, and 
Geometric-mean of 0.34). 
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Table 8 Comparison of the Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using one feature at a time that extracted from Co-expression Network to 
Predict Breast cancer. 
 DTB RUSBOOST 
METHOD ACC F AUC 
G-
MEAN 
ACC F AUC 
G-
MEAN 
DC 0.7593 0.7923 0.7593 0.7403 0.7545 0.7874 0.7545 0.7361 
BC 0.6008 0.6134 0.6008 0.5982 0.5756 0.5834 0.5756 0.5728 
ClosC 0.6415 0.6666 0.6415 0.6363 0.5862 0.6004 0.5862 0.5824 
KSM 0.6415 0.6564 0.6415 0.6396 0.6081 0.6171 0.6081 0.6068 
EC 0.7650 0.7916 0.7650 0.7525 0.7602 0.7875 0.7602 0.7473 
BCS 0.6423 0.6662 0.6423 0.6375 0.5854 0.5987 0.5854 0.5818 
CC 0.6992 0.7274 0.6992 0.6895 0.6691 0.6926 0.6691 0.6630 
FC 0.6984 0.7269 0.6984 0.6885 0.6683 0.6907 0.6683 0.6630 
KSI 0.6333 0.6492 0.6333 0.6308 0.6106 0.6196 0.6106 0.6065 
NC 0.5488 0.2117 0.5488 0.3419 0.5488 0.2117 0.5488 0.3419 
WMZ 0.8187 0.8429 0.8187 0.8040 0.8130 0.8365 0.8130 0.8001 
SC 0.6301 0.6467 0.6301 0.6276 0.6187 0.6343 0.6187 0.6165 
PP 0.6423 0.6672 0.6423 0.6372 0.5862 0.6004 0.5862 0.5824 
SH 0.6366 0.6549 0.6366 0.6335 0.6081 0.6245 0.6081 0.6058 
To assess the power of the individual topological features, we use a different complex 
biological network, Namely, BioGrid PPIs network (i.e. the results are shown in Table 9). 
Comparison to the co-expression network features (Table 8), the BioGrid PPIs network 
features reveal same findings, i.e., DTB and RUSBoost classification models achieve 
highest classification performance using only within module z-score to predict breast 
cancer and non-breast cancer genes. WMZ BioGrid PPIs feature when is fed to DTB and 
RUSBoost is able to provide the highest performance rate, i.e., an accuracy rate of 87% 
(approx.), F-measure rate of 0.89, AUC rate of 0.88 and Geometric-Mean of 0.87. 
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 On the other hand, we observe that Structural Holes (SH) of BioGrid PPIs network 
achieves the lowest classification performance among other topological feature for both 
DTB and RUSBoot classification models (i.e., the accuracy rate of 66% (approx.)). 
BioGrid PPIs features are able to classify better comparison to the features that are 
extracted from co-expression network. 
Table 9 Comparison of the Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using one feature at a time that extracted from BioGrid PPIs Network to 
Predict Breast cancer. 
 DTB RUSBOOST 
METHOD ACC F AUC 
G-
MEAN 
ACC F AUC 
G-
MEAN 
DC 0.8667 0.8797 0.8667 0.8598 0.8618 0.8751 0.8618 0.8551 
BC 0.7341 0.7397 0.7341 0.7336 0.7163 0.7134 0.7163 0.7154 
ClosC 0.6618 0.6759 0.6618 0.6587 0.6472 0.6602 0.6472 0.6447 
KSM 0.7057 0.7156 0.7057 0.7031 0.6959 0.7038 0.6959 0.6940 
EC 0.7325 0.7492 0.7325 0.7283 0.7407 0.7496 0.7407 0.7390 
BCS 0.7772 0.7996 0.7772 0.7683 0.7512 0.7730 0.7512 0.7436 
CC 0.7740 0.7894 0.7740 0.7696 0.7675 0.7787 0.7675 0.7650 
FC 0.7699 0.7852 0.7699 0.7657 0.7415 0.7579 0.7415 0.7373 
KSI 0.7252 0.7349 0.7252 0.7235 0.7041 0.7109 0.7041 0.7029 
NC 0.8650 0.8747 0.8650 0.8615 0.8650 0.8747 0.8650 0.8615 
WMZ 0.8748 0.8866 0.8748 0.8682 0.8772 0.8878 0.8772 0.8718 
SC 0.7821 0.7867 0.7821 0.7798 0.7715 0.7741 0.7715 0.7696 
PP 0.6650 0.6830 0.6650 0.6608 0.6463 0.6608 0.6463 0.6436 
SH 0.6602 0.6754 0.6602 0.6579 0.6106 0.6231 0.6106 0.6095 
Furthermore, a third functional interaction (FI) network is utilized to extract the 
proposed fourteen topological features.  FI fourteen topological features are fed one at a 
time for two different classification models (i.e. DTB and RUSBoost), the classification 
results to predict breast and non-breast genes are shown in Table 10. 
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It is consistently observed that within module z-score (WMZ) (through the three 
biological networks, i.e., co-expression, BioGrid PPIs, and FI networks) achieves the 
highest classification results when is fed to DTB and RUSBoost. WMZ topological feature 
of FI network when is fed to DTB and RUSBoost is able to provide an accuracy rate of 
81% (approx.) for both classifiers. DTB and RUSBoost are also able to predict breast 
cancer genes using only WMZ with F-measure, AUC and Geometric-Mean with rates of 
0.83, 0.81, and 0.79, respectively. 
 On the other hand, we observe that Betweenness centrality (BC) that was extracted 
from FI network achieves the lowest classification performance among other topological 
features for both DTB and RUSBoot classification models (i.e. the accuracy rate of ~64%, 
F-measure rate of 0.67, AUC rate of 0.64, and Geometric-mean of 0.64). Moreover, co-
expression topological features remain to provide the lowest classification performance 
among the other complex biological networks (i.e. BioGrid PPIs and FI networks).  
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Table 10 Comparison of the Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using one feature at a time that extracted from Functional Interaction 
Network to Predict Breast cancer. 
 DTB RUSBOOST 
METHOD ACC F AUC 
G-
MEAN 
ACC F AUC 
G-
MEAN 
DC 0.7837 0.8152 0.7837 0.7647 0.7675 0.8016 0.7675 0.7471 
BC 0.6463 0.6717 0.6463 0.6399 0.6431 0.6674 0.6431 0.6362 
ClosC 0.6805 0.6904 0.6805 0.6790 0.6593 0.6677 0.6593 0.6573 
KSM 0.6602 0.6799 0.6602 0.6571 0.6415 0.6582 0.6415 0.6388 
EC 0.7772 0.8073 0.7772 0.7607 0.7593 0.7911 0.7593 0.7432 
BCS 0.7984 0.8175 0.7984 0.7913 0.7683 0.7856 0.7683 0.7630 
CC 0.6951 0.7350 0.6951 0.6782 0.6748 0.7112 0.6748 0.6628 
FC 0.6878 0.7292 0.6878 0.6695 0.6740 0.7152 0.6740 0.6580 
KSI 0.6561 0.6824 0.6561 0.6501 0.6341 0.6613 0.6341 0.6285 
NC 0.7772 0.8153 0.7772 0.7494 0.7764 0.8152 0.7764 0.7473 
WMZ 0.8049 0.8327 0.8049 0.7874 0.8073 0.8320 0.8073 0.7937 
SC 0.6626 0.6758 0.6626 0.6607 0.6415 0.6498 0.6415 0.6403 
PP 0.6789 0.6887 0.6789 0.6773 0.6569 0.6650 0.6569 0.6550 
SH 0.6878 0.7122 0.6878 0.6820 0.6650 0.6866 0.6650 0.6611 
In summary, „within module z-score‟ is the best feature that is identified using DTB 
and RUSBoost to classify breast cancer and non-breast cancer genes in all three complex 
biological networks (i.e. co-expression, BioGrid PPIs, and FI networks). On the other 
hand, DTB and RUSboost do not provide consistent view of the features that achieve the 
least classification performance among the extracted fourteen topological features. For 
instance, NC feature extracted from co-expression, SH extracted from BioGrid PPIs 
network, and BC extracted from FI network achieve the lowest classification results when 
are fed to DTB and RUSboost classification models to predict breast cancer. 
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6.1.2. Hill-Climbing Feature Selection Classification Performance 
In this section, we show the classification performance adopting hill-climbing feature 
selection technique with two classification model (i.e. DTB and RUSBoost). Three 
complex biological networks are utilized in this study, i.e., co-expression, BioGrid PPIs, 
and FI networks to extract the aforementioned fourteen topological features. These 
fourteen features are fed to DTB or RUSBoost in hill-climbing mode (results shown 
in  Fig. 11.  -  Fig. 16. ) to predict breast cancer genes. DTB and RUSBoost classification 
models with hill-climbing feature selection will select the most significant sub-set of the 
topological features to increase the performance rate of breast cancer prediction. Hill-
climbing approach would provide the optimal classification results, because it investigates 
all possible combination of the given topological features, unlike PCCs which chooses the 
uncorrelated-based features.  
 
 
Fig. 10.  Example of Hill-Climbing Approach 
 
          -                                 
          -                                 
          -                                 
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 Fig. 10.  shows an example of hill-climbing approach, i.e., at first iteration a classification 
model will compute AUC performance rate for every feature. In this example, we assume 
that    gives the highest AUC rate. Then, we fix it and try it with every other feature. 
Further, if     matched with   , we would get a better AUC performance rate. So, we fix 
    with   , and then we try to match them with every other feature. We continue to do 
that, until all combinations are tested and no feature is left to match with.  
Table 12 shows performance rates of two classifiers to predict breast cancer while 
adopting co-expression network, BioGrid PPIs network, and FI network topological 
features individually for co-cross validation tests. The average success rate was greater 
than 80% for RUSBoost and 88% for DTB while using all 14 topological features that 
extracted from any of the individual biological network to predict breast cancer. However, 
when DTB and RUSBoost classifiers were trained with selected features network (i.e. 
selected important features are shown in Table 11), the classification performance 
improved while adopting the selected features (i.e. the results are shown in Table 13). 
Further,  Fig. 11. -  Fig. 16.   show the trends of improvement of classification performance 
of the classifiers in terms of classification accuracy, F-measure, AUC, and Geometric-
mean when using the hill-climbing approach.  
Table 11 shows the topological features that are identified influential in discriminating 
breast cancer using hill climbing approach. For instance, DTB achieved an improvement 
by at least 90% compared to that of using all features in terms of classification accuracy 
(for both co-expression network and FI network individually). However, for BioGrid PPI 
network this performance improvement is 89% compared to that of using all the 14 
topological features.  It is noticeable that the huge improvement in classification accuracy 
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was achieved using 9 topological features for co-expression network and 10 topological 
features for FI network respectively.  Fig. 11. ,  Fig. 13. , and  Fig. 15.  show the trends of 
performance improvement visually for individual networks (i.e. co-expression, BioGrid 
PPIs, and FI, respectively) while using DTB. It is interesting to note that after using few 
selected features the performance starts declining for the both classifiers. This evidently 
guides us to use a subset of the 14 features in place of using all features to accurately 
classify the dataset.  
To further assessing the performance of important topological features, we computed 
F-measure. As shown in Table 13, DTB using 9 topological features of co-expression to 
achieve F-measure value of 0.90, 7 topological features of BioGrid PPIs network to 
achieve F-measure value of 0.90, and 10 topological features of FI network to achieve F-
measure value of 0.90 (i.e.  Fig. 11. ,  Fig. 13. , and  Fig. 15. show the trends improvement 
for co-expression, BioGrid PPIs, and FI networks topological features, respectively). On 
the other hand, RUSBoost classifier uses 8 features of co-expression network to achieve 
maximum F-measure value of 0.82, only 1 topological feature of BioGrid PPIs network to 
attain maximum F-measure of 0.89, and 7 topological features of FI network to achieve F-
measure of 0.84 (i.e. the visual trends improvement are shown in  Fig. 12. ,  Fig. 14. , 
and  Fig. 16. , respectively). 
A similar classification performance improvement trend is achieved when the 
performance of the classifiers is evaluated using area under the curve (AUC). For DTB, 
achieved mean AUC of 0.90 while using 9 topological features of co-expression network 
( Fig. 11. ) , AUC of 0.89 while using 7 topological features of BioGrid PPIs network ( Fig. 
13. ), and AUC of 0.90 while using 10 topological features of FI network ( Fig. 15. ). On 
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the other hand, RUSBoost acquired a mean AUC of 0.82 using 8 features of co-expression 
network ( Fig. 12. ), the maximum classification performance (i.e., AUC value: 0.88) was 
achieved while using only WMZ of BioGrid PPIs network ( Fig. 14. ), for FI network 7 
features is used to achieve AUC of 0.83 ( Fig. 16. ).  
For further assessing the performance of important topological features, we compute 
one more statistical indicator which is Geometric-mean including the ones mentioned 
above, which are accuracy, F-measure and AUC.  However, DTB using 9 topological of 
co-expression network to achieve the highest Geometric mean value of 0.90 ( Fig. 11. ), 7 
topological features of BioGrid PPIs network to achieve maximum Geometric-mean value 
of 0.89 ( Fig. 13. ), For FI network the selected topological features are 10 to achieve a 
Geometric-mean value of 0.90 ( Fig. 15. ). Furthermore, RUSBoost acquired a Geometric-
mean of 0.81 using 8 features of co-expression network ( Fig. 12. ), the maximum 
classification performance (i.e., AUC value: 0.87) was achieved while using only WMZ of 
BioGrid PPIs network ( Fig. 14. ), for FI network 7 features is used to achieve Geometric-
mean of 0.83 ( Fig. 16. ). 
A comparison between Table 12 and Table 13 reveals that utilizing a combination of 
selected features an enhanced classification performance was achieved for both DTB and 
RUSBoost classifiers while adopting any of the individual  biological networks (i.e. co-
expression network, BioGrid PPIs network, or FI network). DTB classifier showed at least 
2% improvements and RUSBoost displayed at least 1% improvements while adopting 
selected set of topological features. 
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Fig. 11.  Comparison of Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using Selected Features Based on Hill-Climbing to Predict Breast Cancer 
using DTB/Co-expression Network Topological Features 
 
 
Fig. 12.  Comparison of Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using Selected Features Based on Hill-Climbing to Predict Breast Cancer 
using RUSBoost/Co-expression Network Topological Features 
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Fig. 13.  Comparison of Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using Selected Features Based on Hill-Climbing to Predict Breast Cancer 
using DTB/BioGrid PPIs Network Topological Features 
 
 
Fig. 14.  Comparison of Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using Selected Features Based on Hill-Climbing to Predict Breast Cancer 
using RUSBoost/BioGrid PPIs Network Topological Features 
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Fig. 15.  Comparison of Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using Selected Features Based on Hill-Climbing to Predict Breast Cancer 
using DTB/FI Network Topological Features 
 
 
Fig. 16.  Comparison of Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using Selected Features Based on Hill-Climbing to Predict Breast Cancer 
using RUSBoost/FI Network Topological Features 
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Table 11 Selected Important Features Based on DTB and RUSBoost Classification 
Models with Hill-Climbing Approach to Predict Breast Cancer From three 
Different Datasets 
 
DTB 
Co-
Expression 
Network 
WMZ NC FC EC ClosC SC BC BCS CC  
BioGrid 
PPIs 
Network 
WMZ DC NC SC KSI BC FC    
FI Network WMZ KSI BCS NC CC DC BC SC FC KSM 
RUSBoost 
Co-
Expression 
Network 
WMZ DC NC CC ClosC KSM SH SC   
BioGrid 
PPIs 
Network 
WMZ          
FI Network WMZ KSI NC PP CC KSM BCS    
 
Table 12 Classification Performance, Accuracy, F-Measure, AUC And Gm Of 5-
Fold   Co-Cross Validation Tests Using All 14 Topological Features 
 DTB RUSBOOST 
METHOD ACC F AUC 
G-
MEAN 
ACC F AUC 
G-
MEAN 
Co-
Expression 
Network 
0.887 0.887 0.887 0.887 0.798 0.801 0.798 0.798 
BioGrid 
PPIs 
Network 
0.885 0.889 0.885 0.883 0.826 0.830 0.826 0.825 
FI 
Network 
0.894 0.892 0.894 0.894 0.816 0.818 0.816 0.815 
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Table 13 The Maximum Classification Performance, Accuracy, F-Measure, AUC 
And Geometric-Mean Of 5-Fold   Co-Cross Validation Tests Using Selected 
Topological Features 
 DTB RUSBOOST 
METHOD ACC F AUC 
G-
MEAN 
ACC F AUC 
G-
MEAN 
Co-
Expression 
Network 
0.903 0.903 0.903 0.903 0.815 0.818 0.815 0.814 
BioGrid 
PPIs 
Network 
0.893 0.896 0.893 0.891 0.877 0.888 0.877 0.872 
FI Network 0.898 0.895 0.898 0.897 0.833 0.836 0.833 0.833 
6.1.3. Pearson Correlation Coefficients (PCCs) Feature Selection 
To provide some insight about the features, we analyze the correlation between each 
pair of the features.  In this regard, we used Pearson correlation coefficients (PCCs) which 
is defined as          
      
      
, where a and b are two zero-mean real valued random 
variables,        is the cross-correlation between a and b,        
   and        
   
[102]. More importantly, we set a threshold of 0.6 to select the highly correlated features. 
 Fig. 17. shows the level of correlation between each pair of the features where the 
features were extracted from co-expression dataset. An analysis of the figure reveals that 
the feature „Within Module Z-core‟ is highly correlated with „Degree Centrality‟, „k-step 
markov centrality‟, „eigenvector centrality‟, „katz status index‟, „Subgraph centrality‟ and 
„Structural holes‟. Further, the feature „Betweenness Centrality‟ is found to be highly 
correlated with the features „Closeness Centrality‟, „Bary-center score‟ and „proximity 
prestige‟. Similarly, „Clustering coefficient‟ is highly correlated with „flow coefficient‟. In 
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summary, the features: „Within module Z-score‟, „Betweennness centrality‟, „Node 
Coreness‟, and „Clustering coefficient‟ are considered to be uncorrelated in the context of 
co-expression network topological features and could be considered for building the 
classification models.  
 
Fig. 17.  Pearson correlation Heat-map of Extracted Features from Co-expression 
network. 
 Fig. 18. shows the level of correlation between each pair of the features where the 
features were extracted from BioGrid PPIs dataset. An analysis of the figure reveals that 
„Within Module Z-score‟ is highly correlated with „Degree centrality‟, „Betweenness 
Centrality‟, „K-step markov centrality‟, „Eigenvector Centrality‟, „Katz Status Index‟, 
„Node Coreness‟, and „Subgraph Centrality‟. Further, „Closeness Centrality‟ is highly 
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correlated with „Proximity Prestige‟. Hence, „Within Module Z-score‟, „Closeness 
centrality‟, „Bary-center score centrality‟, „Clustering coefficient‟, „Flow coefficient‟ and 
„Structural Holes‟ are considered to be uncorrelated and could be used for building 
classification models. 
 
Fig. 18.  Pearson correlation Heat-map of Extracted Features from BioGrid PPIs 
network. 
 Fig. 19. shows the level of correlation between each pair of the features where the 
features were extracted from functional interaction network. More specifically, „Within 
Module Z-score‟ is highly correlated with „Degree centrality‟, „K-step markov centrality‟ 
and „Eigenvector centrality‟. Further, „Betwenness Centrality‟ is highly correlated with 
„Node Coreness‟. In addition, „Closeness Centrality‟ is highly correlated with „Bary-
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Center Score‟. Furthermore, „Proximity Prestige‟ is highly correlated with „Structural 
Holes‟. Hence, „Within Module Z-score‟, „Betweennness centrality‟, „Closeness 
centrality‟, „Clustering coefficient‟, „Flow coefficient‟, „Katz Status Index‟,  „Subgraph 
centrality‟, and „Proximity Prestige‟, are considered to be uncorrelated and could be used 
for building the classification models. 
 
Fig. 19.  Pearson correlation Heat-map of Extracted Features from Functional 
Interaction network. 
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Table 14 Selected Uncorrelated Features Based on Pearson Correlation Coefficients 
to be Considered for Classification From Three Different Networks 
Co-Expression 
Network 
WMZ BC NC CC     
BioGrid PPIs 
Network 
WMZ ClosC BCS CC FC SH   
FI Network WMZ BC ClosC CC FC KSI SC PP 
Table 14 shows the potential selected uncorrelated features based on PCCs that could 
be adopted to build different classification models to predict breast cancer genes. Such 
that, four topological features, six topological features, and eight topological features are 
selected from co-expression network, BioGrid PPIs network, and FI network, respectively. 
These selected topological features from every individual biological network will be used 
to build two classification models (i.e. DTB and RUSBoost) to predict breast cancer and 
non-breast cancer genes.  
 Fig. 20.  shows the classification results of DTB, when is combined with FI network 
topological features we get the best classification performance, i.e., the accuracy rate of 
88% (approx.), F-measure rate of 0.88, AUC rate of 0.88, and Geometric-mean of 0.88.  
RUSBoost while adopting selected topological features based on PCCs either for 
BioGrid PPIs or FI networks, is able to achieve comparable results ( Fig. 21. ) . For 
instance, RUSBoost combined either with BioGrid PPIs network or FI network, is able to 
predict the breast cancer and non-breast cancer genes with an accuracy rate of 80% 
(approx.). Further, RUSBoost combined with BioGrid PPIs or FI network, is able to 
predict the breast cancer genes with F-measure, AUC, and Geometric-mean with rates of 
0.80, 0.80, 0.80, respectively.  
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Fig. 20.  Comparison of Values of Accuracy, F-Measure, AUC, 
and Geometric-Mean using Selected Features Based on PPCs to 
Predict Breast Cancer using DTB 
 
 
Fig. 21.  Comparison of Values of Accuracy, F-Measure, AUC, 
and Geometric-Mean using Selected Features Based on PPCs to 
Predict Breast Cancer using RUSBoost 
In summary, this study shows that the performance rates achieved for DTB combined 
with selected sub-set topological features from Functional Interaction network for breast 
cancer detection is more than satisfactory and, in addition, its automated nature also makes 
it suitable to be used in real clinical conditions. Further, the proposed approach has the 
feasibility of a real-time utilization, after offline training and testing. It is a beneficial to 
develop a system as a result of this study that may provide a robust feedback to the experts 
for the classification of breast cancer quickly and accurately based on the identified 
significant sub-set topological features based on PCCs or Hill-Climbing features selection. 
6.2. Biological Significance of Selected Genes based on Within Module 
Z-score 
The complex biological networks are powerful tools to define the interactions. In 
addition, these tools provide insight to predict the function and the evolution of the 
ACC F AUC Gm
Co-expression 0.8211 0.8215 0.8211 0.821
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components (i.e. genes) in the biological networks. Obviously, the large size of the 
complex biological networks makes it difficult, if not possible, to extract the insightful 
knowledge from such biological networks. In this regard, we have used in this study 14 
topological features with different classifiers that systematically allow identifying patterns 
and predicting phenotypic genes in complex biological networks. These 14 topological 
features could identify a crucial role for the genes in the biological networks, i.e., the most 
central within the network structure. Furthermore, we have analyzed every feature and we 
were able to identify that „Within Module Z-score‟ is the best feature to predict the breast 
cancer genes. Other topological features are identified that might increase the prediction 
performance rate in hill-climbing feature selection approach. However, we focus our 
attention on WMZ and its ability to predict the breast cancer genes. WMZ is based on 
finding modules in the complex biological network, and then ranking the genes in that 
module based on the z-score.  Every module could be arranged in a different manner, i.e., 
some modules could be centralized with one or few nodes connected to all the others. 
Other modules could be decentralized with all nodes having similar connectivies. More 
importantly, nodes with similar roles are predicted to have similar within module 
connectivity.   
Due to the large size of complex biological networks, it is complicated to collect 
insightful knowledge out of hundreds or thousands of vertices and links. Though different 
centralities are computed but every centrality measure lack the ability to identify 
phenotypic genes with high accuracies. However, „within module z-score‟ was proven to 
yield remarkable prediction results with two different classifiers. It is able to extract the 
central nodes based on a scale-specific context through the identification of the crucial 
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modules (clusters).  Hence, the identified modules summarize the connections and 
information of network structure, and that contain components (i.e. genes) of high 
similarities. Moreover, it is likely that the set of connected nodes in a certain module 
reveal similar roles or functions (i.e. related to breast cancer). 
6.2.1. Parameter to Select Hubs Genes based on WMZ 
We define hub genes based on „within module z-score‟, i.e., the nodes with a 
                          are catecorized as module hubs genes, else we classify 
nodes with a                             as non-hubs genes. Hence, the non-hubs 
genes are discarded and only the hubs genes are further studied because they tend to be 
important and they might influence other genes.  Moreover,  Fig. 22. shows the selected 
hubs genes out of co-expression network and their corresponding z-score, i.e., 36 genes 
are selected.  Among the selected genes from co-expression network based on within 
module z-score, there are 18 genes that already known to be related to breast cancer (i.e.,  
POLB, RAB25, FOXM1, TNFRSF1B, AKT1, IRF1, BCL2A1, LSP1, PCM1, RGS16, 
TRIM24, SP2, VDR, CKS2, DDX17, RAB11FIP1, APLP2,  MAD2L1).  
 
Fig. 22.  Within module Z-score of Selected Genes from Co-expression Network. 
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 Fig. 23. shows the selected hubs-genes out of BioGrid PPIs network and their 
corresponding z-score, i.e., 24 hubs-genes are selected and among the selected genes from 
BioGrid PPIs based on within module z-score, there are 23 genes that already known to be 
cancerous except for one genes which is CUL2. 
 
Fig. 23.  Within module Z-score of Selected Genes from BioGrid PPIs Network. 
Furthermore,  Fig. 24. shows the selected genes out of FI network, i.e., 42 hubs-genes 
are selected and among the selected genes from FI network based on within module z-
score, there are 36 genes that already known to be linked to breast cancer except for 6 
genes which are CPSF1, CSNK1A1, DHX38, GTF2F2, GTF2B, NCBP2. 
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Fig. 24.  Within module Z-score of Selected Genes from FI Network. 
Finally, the „Within module z-score‟-based selected genes across the three individual 
biological networks (i.e. co-expression network, BioGrid PPIs network, FI network) 
shows remarkable results. Interestingly, majority of the identified hubs-genes are related 
to breast genes. Nonetheless,   the selected hubs-genes, i.e., they are unknown whether 
they are related to breast cancer or not could be further studied and identify the 
functionally related similarities.  
6.2.2. David’s Tools Analysis  
To provide some insight about the selected genes, we analyze the selected genes using 
Database for Annotation, Visualization and Integrated Discovery (DAVID) [103] to reveal 
which hubs-genes are similar to which hub-genes. Specifically, we use gene similarity 
search tool, this tool incorporates association of set of annotation terms for any given 
gene. Genes tend to participate in similar biological processes, if they are share set of 
those terms. The gene similarity search algorithm, adopts kappa statistics to quantitatively 
measure the degree of the agreement how genes share the similar annotation terms (i.e. 
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kappa values ranges from 0 to 1). Intuitively, the higher the kappa value, the stronger the 
relationship among the genes. More importantly, we set a threshold of 0.6 to select the 
highly similar genes. 
Table 15 shows the selected genes from co-expression network and their corresponding 
functionally related genes with kappa statistics to detect any functional relationship.  For 
instance, „ZNF22‟ gene shows a high functional relationship with „SP2‟ gene (i.e. the 
kappa value is 0.64). This indicates that the two genes „ZNF22‟ and „SP2‟ in considerable 
agreement and highly participate in the same biological processes, more so than by 
random event. Hence, „ZNF22‟ is highly involved to breast cancer.   
Table 15 Selected Genes from Co-expression Network based on Within Module Z-
score and their Corresponding Functionally Related Genes. 
Symbol 
Entrez 
Gene ID 
Breast 
Cancerous 
Functionally Related Genes (Kappa rate) 
PRPS2 5634 Unknown None 
POLB 5423 Known None 
RAB25 57111 Known None 
MED20 9477 Unknown 
PBX2 (0.40), GTF2E2 (0.39), FOXM1(0.37), 
SP2(0.36), 
TOMM
70A 
9868 Unknown None 
PBX2 5089 Unknown 
SPI1(0.47), IRF1(0.45),GTF2H1(0.42), 
MED20(0.40) 
FOXM1 2305 Known 
SP2(0.40), IRF1(0.38), MED20 (0.37), SPI1 
(0.37), GTF2E2 (0.37) 
ZNF22 7570 Unknown SP2 (0.64), ZNF24 (0.62) 
CNN1 1264 Unknown None 
ZNF24 7572 Unknown 
SP2(0.67), ZNF22(0.62), SPI1(0.41), 
TRIM24(0.36) 
PKN2 5586 Unknown None 
TNFRS
F1B 
7133 Known None 
GTF2H
1 
2965 Unknown GTF2E2(0.45), PBX2(0.42) 
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GTF2E2 2961 Unknown GTF2H1 (0.45), MED20(0.39), FOXM1(0.37) 
AKT1 207 Known None 
IRF1 3659 Known PBX2(0.45), SPI1(0.44), FOXM1(0.38) 
BCL2A
1 
597 Known None 
LSP1 4046 Known None 
PCM1 5108 Known None 
RGS16 6004 Known None 
ITGAE 3682 Unknown None 
COL3A
1 
1281 Unknown None 
TRIM24 8805 Known VDR(0.38), ZNF24(0.36), SPI1(0.36) 
SP2 6668 Known 
ZNF24(0.67), ZNF22(0.64), FOXM1(0.40), 
MED20(0.36) 
VDR 7421 Known TRIM24(0.38) 
CKS2 1164 Known None 
RBM17 84991 Unknown None 
DDX17 10521 Known None 
HLA-
DMA 
3108 Unknown None 
PPP3CC 5533 Unknown None 
RAB11
FIP1 
80223 Known None 
APLP2 334 Known None 
NID2 22795 Unknown None 
SPI1 6688 Unknown 
PBX2(0.47), IRF1(0.44),ZNF24(0.41), 
FOXM1(0.37), TRIM24(0.36) 
CUL2 8453 Unknown None 
MAD2L
1 
4085 Known None 
Table 16 shows the functionally related genes that are selected based on „within 
module z-score‟ from BioGrid PPIs network. Interestingly, all selected genes are known to 
be involved in breast cancer except for „CUL2‟ genes. „CUL2‟ is highly functionally 
related to „CUL4A‟ and „CUL1‟ genes with kappa values of 0.85 and 0.66, respectively. 
These achieved kappa statistics values indicate strongly that „CUL2‟ gene is involved in 
breast cancer. 
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Table 16 Selected Genes from BioGrid PPIs Network based on Within Module Z-
score and their Corresponding Functionally Related Genes. 
Symbol 
Entrez Gene 
ID 
Breast 
Cancerous 
Functionally Related Genes (Kappa 
Rate) 
CDK2 1017 Known None 
ELAVL1 1994 Known None 
COPS5 10987 Known None 
CUL1 8454 Known CUL2(0.66), CUL4A(0.66) 
TP53 7157 Known PML(0.45), SMAD3(0.35) 
CUL2 8453 Unknown CUL4A(0.85), CUL1(0.66) 
SUMO1 7341 Known None 
MYC 4609 Known None 
GRB2 2885 Known SHC1(0.52) 
SP1 6667 Known None 
SHC1 6464 Known GRB2(0.52) 
HDAC2 3066 Known 
HDAC3(0.49), SMARCA4(0.40), 
RB1(0.37) 
HDAC3 8841 Known HDAC2(0.49) 
PML 5371 Known TP53(0.45) 
CBL 867 Known None 
CUL4A 8451 Known CUL2(0.85), CUL1(0.66) 
SMARCA
4 
6597 Known HDAC2(0.40) 
SMAD3 4088 Known TP53(0.35) 
H2AFX 3014 Known None 
RB1 5925 Known HDAC2(0.37) 
VHL 7428 Known None 
MAPK1 5594 Known AKT1(0.37) 
AKT1 207 Known MAPK1(0.37) 
CTNNB1 1499 Known None 
Table 17 shows the functionally related genes that are selected based on „within 
module z-score‟ from Functional Interaction network. There are 6 unknown genes whether 
they are involved in the breast cancer. However, among these genes is „GTF2F2‟ gene 
which shows a high similarities with „GTF2F1‟ (i.e. kappa value is 0.69). This is a strong 
indication that „GTF2F2‟ share major biological processes with „GTF2F1‟, hence, 
„GTF2F2‟ could be strongly involved in breast cancer disease.  
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Table 17 Selected Genes from FI Network based on Within Module Z-score and 
their Corresponding Functionally Related Genes. 
Symb
ol 
Entrez 
Gene 
ID 
Breast 
Cancero
us 
Functionally Related Genes (Kappa rate) 
AKT1 207 Known MAPK1(0.37) 
CTN
NB1 
1499 Known None 
ACT
B 
60 Known None 
GRB2 2885 Known MAPK3(0.41), PIK3R1(0.36) 
JUN 3725 Known FOS(0.53) 
MAP
K1 
5594 Known MAPK3(0.65), AKT1(0.37), GSK3B(0.36) 
MAP
K3 
5595 Known 
MAPK1(0.65), CSNK2A1(0.43), GRB2(0.41), 
CDK4(0.39), PIK3CA(0.39), CDK2(0.36) 
CDK
2 
1017 Known 
CDK4(0.66), CDK7(0.49), CSNK2A1(0.46), 
CSNK1A1(0.41), MAPK3(0.36) 
CRE
B1 
1385 Known FOS(0.36) 
CDK
7 
1022 Known 
CCNH(0.61), GTF2F2(0.52), CDK2(0.49), CDK4(0.47), 
GTF2F1(0.42), CSNK2A1(0.39), CSNK1A1(0.37) 
CCN
D1 
595 Known None 
FOS 2353 Known JUN(0.53), CREB1(0.36) 
GTF2
F1 
2962 Known GTF2F2 (0.69), GTF2B(0.52), CCNH(0.49), CDK7(0.42) 
FYN 2534 Known LCK(0.41), ABL1(0.38), 
CBL 867 Known None 
APC 324 Known None 
CASP
3 
836 Known None 
CD4 920 Known None 
ABL1 25 Known FYN(0.38), LCK(0.38) 
CCN
H 
902 Known 
CDK7(0.61), GTF2F2(0.52), GTF2F1(0.49), 
GTF2B(0.42) 
GSK3
B 
2932 Known CSNK1A1(0.39), MAPK1(0.63) 
ITGB
1 
3688 Known None 
ATF2 1386 Known None 
CPSF
1 
29894 
Unknow
n 
None 
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LCK 3932 Known FYN(0.41), ABL1(0.38) 
PIK3
R1 
5295 Known PIK3CA(0.47), GRB2(0.36) 
PIK3
CA 
5290 Known PIK3R1(0.47), MAPK3(0.39) 
HDA
C2 
3066 Known None 
CSN
K1A1 
1452 
Unknow
n 
CSNK2A1(0.55), CDK4(0.45), CDK2(0.41), 
GSK3B(0.39), CDK7(0.37) 
DHX
38 
9785 
Unknow
n 
GTF2F2(0.43) 
CDK
4 
1019 Known 
CDK2(0.66), CDK7(0.47), CSNK2A1(0.46), 
CSNK1A1(0.45), MAPK3(0.39) 
HNR
NPA1 
3178 Known NCBP2(0.50) 
AUR
KA 
6790 Known None 
GTF2
F2 
2963 
Unknow
n 
GTF2F1(0.69), CDK7(0.52), CCNH (0.52), 
GTF2B(0.44), DHX38(0.43) 
MYC 4609 Known None 
CSN
K2A1 
1457 Known 
CSNK1A1(0.55), CDK4(0.46), CDK2(0.46), 
MAPK3(0.43), CDK7(0.39) 
HSP9
0AA1 
3320 Known None 
FN1 2335 Known None 
NFK
B1 
4790 Known None 
GTF2
B 
2959 
Unknow
n 
GTF2F1(0.52), GTF2F2(0.44), CCNH(0.42) 
NCB
P2 
22916 
Unknow
n 
HNRNPA1(0.50) 
COL1
A1 
1277 Known None 
Finally, we shed the light specifically on three genes which are „ZNF22‟ from co-
expression network, „CUL2‟ from BioGrid PPIs network, and „GTF2F2‟ from FI network. 
These three genes showed high similarities in term of kappa values. However, the other 
selected unknown genes are highly potential candidates to be involved in breast cancer 
disease.  
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6.3. Impact of our Work 
In our work, we are able to identify significant sub-set of topological features that 
could help biologists and researchers to adopt those biological features to study the 
structure and functions of biological networks. Specifically, we found that 'within module 
z-score' and 'node coreess' topological features have the ability to accurately identifying 
the central genes (i.e. hub-genes that are highly connected to other genes) when are fed to 
two classifiers. Hub-genes are potential candidates that must be studied because they are 
essential to influence other neighboring genes.  
Furthermore, 'within module z-score' is utilized to perform in-depth analysis. 
Particularly, we set a threshold that any gene has a within module z-score equal or greater 
2.5, then it is selected to be a hub-gene. Interestingly, we observed that the majority of 
selected hubs-genes are involved in breast cancer disease. Obviously, the selected hubs-
genes that are unknown whether they are involved in breast cancer disease, they are 
potential candidates to be related to breast cancer. However, a gene similarity analysis 
revealed that „ZNF22‟ from co-expression network, „CUL2‟ from BioGrid PPIs network, 
and „GTF2F2‟ from FI network provide high statistical significance that are participating 
in biological processes that typically breast cancerous genes are involve in. Hence, our 
analysis suggests that „ZNF22‟, „CUL2‟, and „GTF2F2‟ are involved in breast cancer 
diseases. 
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CHAPTER 7 
CONCLUSION AND FUTURE WORK 
The bioinformatics techniques that are studied for disease-gene association are 
evaluated using three publicly available datasets (i.e. co-expression, BioGrid PPIs, and FI 
networks). These complex biological networks were utilized to apply analysis for breast 
cancer prediction. The work of this study could be divided into three folds. Firstly, the 
graph theory discipline which has been a significant part to studying complex biological 
networks. It has been applied to different complex biological networks to extract hidden 
knowledge (i.e. we have used fourteen ranking algorithms for every network). These 
topological properties are then fed into different classification models as features. 
Secondly, the phenotype that has been studied (i.e. breast cancer) is associated with a few 
number of samples. Thus, the negative classes are far more in number than in the positive 
classes. For this reason, a SMOTE sampling mechanism is adopted to overcome the 
problem of unbalanced datasets. Thirdly, at this stage, different classification models, such 
as: decision tree bagger and RUSBoost, are implemented to discriminate between the 
positive classes and negative classes. Moreover, the power of network topology analysis is 
limited, as we are dealing with the biological networks as a statics perspective, which in 
fact they are highly dynamic systems. Thus, the used biological networks have been 
randomized and the classification results are generated once again in the attempt to reveal 
some hidden patterns that are uncovered from the real networks. However, it remains the 
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study of dynamic biological network over-times a bottleneck which will be investigated 
more in our future research. 
7.1. Limitations  
In this research, we were able to build a systematic approach that could association 
genes to diseases. However, there were some limitations of this study because of its 
nature. First, only one balanced sampled datasets are generated from each network 
topological features using SOMTE. We could get more insights about the classification 
performance significance by generating more number of sampled datasets using SMOTE 
or even using different sampling techniques. Second, the classification performance could 
be improved by extracting more robust topological features. Third, different classifiers 
need to be tested that might provide a better classification performance, and different weak 
learners could be ensemble.  
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Appendix A 
In this appendix, we include a number of results that were omitted from the main 
thesis write-up. In section A, we show the classification performance using the fourteen 
extracted topological features from the randomized co-expression, BioGrid PPIs, and FI 
networks to predict breast cancer genes.  
A Randomized Co-expression, BioGrid PPIs, and FI networks 
Features Classification Performance 
In this section, we show the classification performance using all fourteen topological 
features at once to predict the breast cancer and non-breast cancer genes. More 
importantly, these fourteen topological features are extracted from the randomized 
models of the three complex biological networks (i.e. co-expression network, BioGrid 
PPIs network, and FI network). The adopted randomization scheme is illustrated in 
chapter  4, section  4.3. Then, these fourteen topological features that have been extracted 
from the randomized biological networks are fed to two different classification models 
i.e., DTB and RUSBoost (results shown in Table 18) to predict breast cancer genes. 
A.1 Classification Performance using Fourteen Topological Features 
Cancer phenotype participates in dysregulation of several pathways controlling 
essential cell processes [104] (e.g. breast cancer phenotype). In this case, the complex 
biological networks are affected by having altered pathways (in other words, the 
interactions are altered), which will cause a genetic mutation dependent on the 
environmental context. Moreover, the potential of topological properties analysis is not 
fully utilized since we are dealing solely with statics networks. Rather the complex 
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biological networks tend to be highly dynamics, as new interactions and genes are 
involved in the biological processes. Hence, the utilization of the randomized network 
provides the advantages of covering the hidden patterns that might be under (or over) 
represented in the real network. Therefore, a randomized version of the three biological 
networks (i.e. co-expression network, BioGrid PPIs, and FI) is generated based on the 
Maslov et al. technique. The fourteen topological properties are then applied to extract the 
features. Prior classification, the raw data are balanced using SMOTE (i.e. the positive and 
negative samples are equal to 615). Next the classification models are applied to predict 
the breast cancer and non-breast cancer genes using the extracted features from the 
randomized network. The results are shown in Table 18. 
The randomized BioGrid PPIs network topological features when are adopted for any 
classification model (i.e. DTB or RUSBoost); tend to provide highest classification 
performance. More specifically, DTB combined with randomized BioGrid PPIs network 
topological features provide best classification results. Further, DTB/ randomized BioGrid 
PPIs topological features is able to predict breast cancer  and non-breast cancer genes with 
an accuracy rate of 87% (approx.), and could predict breast cancer genes correctly with  F-
measure rate of 0.88, AUC rate of 0.87, and geometric-mean rate of 0.87 (Table 18) 
Secondly, the RUSBoost achieved the second best classification performance using the 
randomized PPIs network topological features, where the accuracy, F-measure, AUC, and 
geometric-means are 83% (approx.), 0.84, 0.83, and 0.83, respectively.  
Moreover, the randomized co-expression network topological features, when used for 
training and testing the DTB and RUSBoost, the classification trends are slightly better 
than using the randomized FI network (Table 18).  
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Table 18 Comparison of the Values of Accuracy, F-Measure, AUC, and Geometric-
Mean using All Fourteen Features to Predict Breast cancer. 
 DTB RUSBOOST 
METHOD ACC F AUC 
G-
MEAN 
ACC F AUC 
G-
MEAN 
Co-
Expression 
Network 
0.871 0.87 0.871 0.871 0.775 0.777 0.775 0.774 
BioGrid PPIs 
Network 
0.872 0.878 0.872 0.87 0.832 0.835 0.832 0.832 
FI Network 0.867 0.869 0.867 0.867 0.77 0.773 0.77 0.769 
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Appendix B 
In this appendix, we include a number of results that were omitted from the main 
thesis write-up. In Section B, we provide classification results following the same 
procedure applied in the thesis on four disease specific gene association networks.  
B Disease Specific Gene Association Networks 
In our thesis work, we have extracted fourteen features from publicly gene expression 
profiles, protein-protein interaction networks, and functional interaction network. Then, 
we used a sampling technique SMOTE to overcome the problem of imbalanced datasets 
that are inherited in nature in such types of datasets. After that, the imbalanced datasets are 
used to train the classification models (i.e. decision tree bagger and RUSBoost) to 
investigate the phenotype-gene association in breast cancer. More importantly, in this 
section we validate our approach that has been proposed in this thesis using more four 
disease specific gene association networks to reveal breast cancer genes patterns. 
In analogy with our previous procedure, we have built also two classification models 
that could be used for discriminating breast cancer genes in more four datasets which are 
disease specific gene association networks. The classification results are shown in Table 
19. 
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Table 19 Disease Specific Networks Classification Performance To Predict Breast 
Cancer Genes 
CLASSIFIER  
BASAL 
NETWORK 
HER2 
NETWORK 
LUMA 
NETWORK 
LUMB 
NETWORK 
DTB 
ACC 
0.931 
  
0.005 
0.927 
  
0.006 
0.923 
  
0.008 
0.929 
  
0.013 
F 
0.935 
  
0.005 
0.931 
  
0.006 
0.927 
  
0.008 
0.929 
  
0.013 
AUC 
0.931 
  
0.005 
0.927 
  
0.006 
0.923 
  
0.008 
0.929 
  
0.013 
G-Mean 
0.929 
  
0.006 
0.925 
  
0.006 
0.921 
  
0.008 
0.929 
  
0.013 
RUSBOOST 
ACC 
0.902 
  
0.005 
0.892 
  
0.004 
0.881 
  
0.008 
0.875 
  
0.01 
F 
0.903 
  
0.005 
0.894 
  
0.003 
0.883 
  
0.008 
0.876 
  
0.01 
AUC 
0.902 
  
0.005 
0.892 
  
0.004 
0.881 
  
0.008 
0.875 
  
0.01 
G-Mean 
0.902 
  
0.005 
0.891 
  
0.004 
0.881 
  
0.008 
0.875 
  
0.01 
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The proposed methodology in this thesis showed great potential when it was tested 
using three publicly available datasets: co-expression network, protein-protein interactions 
network, and function interaction network. Furthermore, we validate the strength of our 
proposed fourteen topological features along with the selected classification models 
performance in predicting the phenotype-gene association using features extracted from 
different four disease specific networks. Table 19 reports the performance measures which 
are defined earlier, and more importantly the table show a comparison among three 
classification models (i.e. decision tree bagger and RUSBoost). Obviously, decision 
bagger provides best classification results which adopt SMOTE sampling technique and 
using the topological features extracted from disease specific gene association networks. 
That is an indication of the strength of the generated rules of the decision tree bagger 
during the training phase. Moreover, that is also shows the efficiency of the used co-
crossed validation that is proposed in this study to obtain high and efficient classification 
performance rates during the testing phase.  
The classifiers are evaluated with accuracy rate, along with other performance 
measures (i.e. F-measure, AUC, geometric mean) to provide a better indication of the 
classification performance. However, the combination of Basal gene specific network and 
decision tree bagger achieved the highest classification performance in term of accuracy, 
F-measure, AUC, and geometric mean. Such that, the accuracy rate is 0.931, this shows 
how the decision tree bagger capable to correctly classify cancerous and non-cancerous 
breast cancer genes. On the other hand, geometric mean which is an efficient metrics for 
unbalanced datasets showed a proportion of 0.929 which is an indication of capability of 
decision tree bagger to classify breast cancerous genes correctly.  
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